Next Article in Journal
Mapping Socio-Environmental Drivers of Zoonotic Diseases in Brazil
Previous Article in Journal
Enduring Warning: A Holistic Comparison of the Establishment and Spread of P. falciparum Evolutionary Lineage Malaria in Ancient Rome and the Threat of Zoonotic P. knowlesi Malaria in Modern Southeast Asia
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Navigating Zoonotic Landscapes: From Genomic Insights to Ethical Frontiers

1
Department of Pharmaceutics & Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan
2
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13132, Jordan
3
Department of Pharmaceutical Sciences, Center for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA
4
Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa 13132, Jordan
5
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan
6
School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India
7
School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India
8
College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates
9
North Wales Medical School, Bangor University, Brigantia Building, Penrallt Road, Bangor LL57 2AS, UK
*
Authors to whom correspondence should be addressed.
Zoonotic Dis. 2025, 5(4), 35; https://doi.org/10.3390/zoonoticdis5040035
Submission received: 21 September 2025 / Revised: 31 October 2025 / Accepted: 11 November 2025 / Published: 13 November 2025

Simple Summary

Viruses that move from animals to humans, known as zoonotic viruses, pose an ongoing challenge to global health. Outbreaks such as Ebola, avian influenza, and COVID-19 have shown how changes in the environment, human behavior, and viral evolution can trigger new diseases. This review explains how these infections emerge, describing the biological, ecological, and social factors that allow viruses to cross species barriers. It also discusses how genomic research helps scientists understand how viruses adapt to new hosts and how this knowledge supports early detection and prevention. The review emphasizes the importance of the One Health approach, which links human, animal, and environmental health, to reduce future spillover risks. By integrating science, ethics, and public policy, this work highlights practical ways to prevent future pandemics and promote a safer balance between human activity and nature.

Abstract

Viral zoonoses represent a critical intersection of global health, ecology, and ethical issues. Pathogens that pass from animals to humans. This review examines the complex landscape of viral zoonoses, including their mechanisms, impact, and mitigation strategies. We begin with insights into the historical context and significance of these diseases and then explore spillover mechanisms influenced by genetic, ecological, and anthropogenic factors. This review covers the host range, transmission dynamics, and immunological barriers, including viral detection, adaptation, and immune evasion. Genomic insights have revealed the genetic determinants of host switching and adaptation, illuminating the dynamics of viral spillover events. We emphasize the anticipation and prevention of zoonotic events, highlighting surveillance, early warning systems, and the “One Health” approach. Using case studies of outbreaks such as Ebola, avian influenza, and COVID-19, this review examines the real-world consequences of zoonotic diseases. We then discuss interventions, including mitigation strategies and vaccination, and their ethical and social implications. Drawing on past outbreaks, we provide recommendations for the future, aiming to balance human health, conservation, and animal welfare. This review aims to inform professionals, academics, and policymakers by offering a multidisciplinary perspective on the complex world of viral zoonoses and strategies to protect global health.

Graphical Abstract

1. Introduction

Viral zoonoses are infectious diseases caused by viruses that naturally live in animals and can be transmitted to humans. They represent a significant and complex global health threat. Understanding the dynamics of these diseases is crucial for developing effective control strategies. Several interrelated factors have led to the emergence of viral zoonoses [1]. The One Health Initiative has identified the need to understand bacterial and viral zoonoses among the diseases prioritized in workshops held in various countries [2]. The overall risk factors for human disease emergence are complex, with helminths being the parasites most strongly associated with human zoonoses, followed by viruses, protozoa, bacteria, and fungi [3].
Emergent and re-emergent viral zoonoses are multivariate and are influenced by environmental changes, human demographics and behavior, and, of course, viral factors themselves [4]. The establishment of viral zoonoses is associated with increased human transmission in their ecological and evolutionary contexts [5]. Such factors include viral isolates from non-human primates, the human respiratory tract, and the CNS, which further influence the virus’s transmissibility [6]. For instance, mathematical modelling has been used to study viral zoonoses in wildlife to provide a framework for understanding and predicting their dynamics. However, most zoonotic viruses are RNA viruses, which are more prone to zoonotic transmission than DNA viruses [7]. Genomic size and host range contribute to the estimation of a zoonotic virus’s potential to emerge and persist in transmission. Therefore, it is increasingly important to understand the potential of a zoonotic virus circulating among wildlife hosts, exemplified by Ebola and SARS-CoV-2 [8,9]. The potential of zoonotic influenza viruses to adapt to humans and acquire human-to-human transmissibility is a reminder of their ability to cause pandemics [10]. Zoonotic viruses arise in animal populations through mutation and reassortment, giving rise to new strains capable of causing human infections [11].
The way these pathogens jump to humans matters. Direct spillover highlights the importance of frontline surveillance in communities with high wildlife exposure, whereas indirect spillover underscores the need to monitor intermediate hosts that serve as amplification points. Integrating genomic signals from both pathways allows risk models to move beyond description to actionable early-warning systems [12].
Finally, information on viral zoonoses is multifaceted, ranging from reservoirs to risk factors for emergence, transmissibility, and zoonotic virus characteristics. The findings of this study are important for the prevention and control of such zoonotic diseases. Major zoonotic viruses have caused devastating pandemics due to their animal origins and their ability to transmit to humans. The recent outbreaks of SARS, MERS, Ebola, Zika, and COVID-19 are stark reminders of this constant threat. Most of these depend on complex interactions among factors, such as human activity, environmental changes, and viruses’ intrinsic ability to mutate and adapt, enabling them to emerge and transmit successfully [13,14,15]. Effectively tackling these diseases requires understanding this complex interplay. This requires interdisciplinary collaboration between virology, ecology, epidemiology, veterinary medicine, and public health to develop proactive strategies. Only with a comprehensive, integrated approach can we hope to prevent future outbreaks [16,17]. Table 1 identifies the strengths, weaknesses, opportunities, and threats of zoonotic disease research. This SWOT analysis can help policymakers make informed decisions and develop effective strategies to mitigate the risks associated with these diseases, as well as to prioritize resources to address current challenges and prevent potential threats.
In this review, we specifically aimed to analyze the genomic determinants of zoonotic viral adaptation, ecological and anthropogenic drivers of spillover, and ethical considerations in prevention strategies. This focus ensures that the review is positioned as a rigorous and scholarly contribution rather than a descriptive overview.

2. Methodology

To frame this review, we adopted a structured narrative approach. We searched PubMed, Scopus, and Web of Science for articles published between January 2010 and March 2025. Search terms included ‘zoonotic viruses,’ ‘viral spillover,’ ‘comparative genomics,’ ‘host adaptation,’ and ‘One Health.’ PubMed, Scopus, and Web of Science for literature published between January 2010 and March 2025. Our search terms included ‘zoonotic viruses,’ ‘viral spillover,’ ‘comparative genomics,’ ‘host adaptation,’ and ‘One Health.
We included peer-reviewed research articles, systematic reviews, and authoritative reports from international health agencies in our analysis. The exclusion criteria were non-peer-reviewed opinion pieces, case reports without genomic or epidemiological analysis, and articles published in languages other than English. In our selection process, we prioritized these sources while generally excluding non-peer-reviewed opinion pieces, case reports that lacked genomic or epidemiological analysis, and articles not published in English.
While the primary focus was on studies from 2010 onwards to ensure currency, seminal earlier works were also included, as they provided essential conceptual or historical context. Although we concentrated on literature from 2010 onwards to keep the review current, we also drew on foundational earlier works where they provided necessary historical or conceptual grounding.
Studies were evaluated for relevance to three domains: (1) genomic determinants of host switching and viral adaptation, (2) ecological and anthropogenic drivers of spillover, and (3) ethical implications of the interventions. We then synthesized the findings thematically, aiming to map out the current state of knowledge, point to ongoing controversies, and identify key questions that remain unanswered. This methodology ensures a transparent, reproducible, and scholarly foundation for this review.

2.1. Advantages and Disadvantages

Studying viral zoonoses is crucial for human and animal health, but the work is not without its own hurdles and ethical dilemmas [18]. One clear benefit is the potential to predict and control new threats to prevent catastrophic pandemics. Furthermore, research on zoonotic diseases may provide a broader window into the dynamics between the host and pathogen, thereby contributing to general knowledge of virology [19]. At the same time, we must consider the disadvantages and complexities inherent in this work. Research in this area often requires close contact with wildlife and domestic animals, increasing the likelihood of zoonotic pathogen spillover to researchers [20]. There is an ethical clash between conservation and disease management because interventions to limit zoonotic spillover may require actions such as culling or altering natural habitats. Balancing public health and ecological preservation remains an ongoing challenge. Taken together, viral zoonoses are a central area of study in virology, public health, and ecology, posing significant challenges to global health security while also offering great opportunities for scientific advances and pandemic prevention [21,22].
In this review, we explore these subtle issues, touching on definitions, historical context, and epidemic examples, with a particular focus on spillover and cross-species transmission. We hold a balanced perspective, weighing the pros and cons of any intervention while considering the potential impacts on both ecosystems and human health. A more complete understanding of spillover events and cross-species transmission is needed to understand the origins of novel zoonotic diseases and to formulate strategies to prevent and control them. Hence, we believe the benefits of this research ultimately outweigh the potential downsides. This research is indispensable for protecting human health from the growing threat of emerging infectious diseases [23]. Understanding the mechanisms underlying spillover and cross-species transmission will enable us to develop interventions that limit the risk of new outbreaks and generate new vaccines and treatment options for zoonotic diseases [24,25].

2.2. Viral Zoonoses Feature Important Points That Experts Focus on in Their Evaluations

The basic idea is to identify viral genetic traits and host factors that shape the virulence, transmissibility, and zoonotic potential of viruses, thereby predicting such events and preventing them. The thinking here is straightforward: if we can identify the viral genetic traits and host factors that shape virulence, transmissibility, and zoonotic potential, we have a better chance of predicting and preventing these events. Special focus has also been given to the host genetic component in determining the success of viral zoonoses, because viral variants compatible with humans must preexist in animal reservoirs from which they are zoonotically derived [26]. For example, the furin-like cleavage site in the SARS-CoV-2 spike glycoprotein is critical for both viral entry and pathogenesis, as supported by several studies [27]. Therefore, its presence is of great importance and is a significant marker associated with specific viral features, potentially providing determinants of interspecies transmission. This finding is significant because the presence of such a site can serve as a key marker, potentially offering clues about a virus’s capacity for interspecies transmission.
This type of viral diversity shows that continuous surveillance and viral discovery in animals and humans are equally important, as part of the One Health approach, which concerns the linkages among human, animal, and environmental health in the context of understanding zoonotic diseases. This diversity underscores why continuous surveillance and viral discovery in both animals and humans are so critical. It is all part of the One Health approach, which recognizes the interconnectedness of human, animal, and environmental health. Studies on wild mammals in Mexico have documented that the nation is a vital host for various zoonotic viruses. Knowing which viruses are directly transmitted from wildlife would be critical to preventing their spread into human populations [28,29]. Ecological drivers such as deforestation, wildlife trade, and climate change have been widely recognized as factors that increase spillover risk. Deforestation reduces natural habitats, forcing closer contact between humans and wildlife. Wildlife trade amplifies cross-species encounters, while climate change alters vector distributions and disease ranges. These processes are not independent but interact with genomic determinants of viral adaptation. For example, land-use change has been linked to the emergence of Nipah virus in Malaysia, where agricultural expansion increased bat–pig–human contact and facilitated viral amplification [30,31]. Similarly, wildlife trade networks have accelerated the spread of avian influenza subtypes, creating opportunities for recombination in live animal markets. Climate-driven changes in mosquito habitats have also been shown to influence Rift Valley fever outbreaks, with viral strains adapting to new ecological niches. These cases illustrate how ecological disruptions act as enabling conditions for genomic shifts that drive zoonotic emergence [32,33]. What these cases show is how ecological disruptions can create the enabling conditions for the very genomic shifts that drive zoonotic emergence.
Furthermore, climatic conditions influence the distribution of animal reservoirs and vectors, as well as their behavior, driving the emergence of zoonoses. It is also clear that climate influences the distribution of animal reservoirs and vectors, as well as their behavior, which in turn drives the emergence of zoonoses. Future research should focus on how climate variability alters the dynamics of viral zoonosis and on possible mitigation strategies [33,34]. A comprehensive view of viral zoonosis, therefore, needs to integrate the viral and host factors that enable cross-species transmission, recognize the role of host genetics, and emphasize the need for continual surveillance in both animals and humans, all while accounting for the profound impact of environmental change (as shown in Table 2). Addressing these aspects is how we, as a scientific community, can begin to fill the gaps in our understanding and mitigate the risks associated with viral zoonoses [35].

3. Mechanisms of Viral Spillover

3.1. Direct and Indirect Spillover Pathways

Pinpointing the mechanisms of spillover is fundamental to reducing risk. The spillover of viruses can be either direct or indirect, as shown in Figure 1; it may occur directly during interhost transmission, depending on the genetic, ecological, and anthropogenic factors that govern the transfer of the virus from an infected animal to a human [36], and the route it takes is governed by a mix of genetic, ecological, and anthropogenic factors that control the virus’s jump from an animal to a human.
Therefore, viral spillovers proceed directly from animal-to-human contact through bites, scratches, or contact with body fluids when the animal is infected; for instance, the transmission of viruses through dog bites. Direct spillover refers to the transfer of a virus from an infected animal to an unexposed host [37]. With direct spillover, the virus moves straight from an animal to a person. Direct spillovers can occur through various natural and human activities, including hunting, butchering, or eating contaminated animals.
In contrast, indirect spillovers involve an intermediate host before transitioning to humans. One example is the Zika virus, which spreads through the bites of infected Aedes mosquitoes. Indirect spillovers result from complex interaction networks. In most cases, an intermediary host is required, in which the virus must adapt before infecting humans. Indirect spillover, on the other hand, is more circuitous. Here, the virus first passes through an intermediate host. This is where things get complex, as the virus often needs to adapt to this new animal before it can make the jump to humans. The Zika virus is a classic example, spreading to people through the bite of an infected Aedes mosquito.

3.2. Genetic Determinants of Spillover

Getting a better handle on the dynamics of these direct and indirect spillovers is what will ultimately lead to better interventions. Viral spillover does not occur randomly; several factors modulate it. The probability of transmission from animals to humans is not a random event; it is shaped by a combination of factors that influence the odds of a virus making the jump from an animal to a human [38]. These factors are broadly categorized as genetic, ecological, and anthropogenic. Genetic changes within the virus itself are often a primary driver of spillover. Viruses, especially RNA viruses, such as influenza and coronaviruses, have high mutation frequencies. Mutations can alter viral proteins, enabling the virus to infect new hosts [39]. Other cases include recombination between the genetic material of different viruses, which often yields new strains that may modify the host preference. Genetic plasticity is characteristic of most zoonotic viruses.

3.3. Ecological Drivers of Spillover

Environmental ecology is increasingly recognized as a key determinant of viral spillover [40]. Host ecology, including population density, behavior, and migratory patterns, strongly influences the likelihood of exposure between humans and infected animals. Habitat disruption from activities such as deforestation, urbanization, and climatic instability may bring humans into closer contact with wildlife, which elevates the likelihood of viral spillover. Understanding the ecological drivers of these potential reservoir species is therefore essential to predicting and preventing zoonotic outbreaks.

3.4. Anthropogenic Drivers of Spillover

Human actions significantly increase the likelihood of viral spillover [40,41]. Urbanization extends human habitats into once-wild areas, fostering interactions between humans and wildlife. Both legal and illegal wildlife trade create pathways for viruses to cross species barriers. Wildlife markets, where an assemblage of species is brought together in close proximity, can provide a perfect environment for the rapid amplification and dissemination of viruses.

3.5. Case Studies of Historical Spillovers

Preventing zoonotic diseases requires mitigating anthropogenic drivers. To concretize the various aspects of viral spillover, we provide extended descriptions of several historical zoonotic events in this section [42]. To illustrate these aspects, we describe several historical zoonotic events. Pathoecological analyses of these cases examine the pathways viruses use to cross species boundaries, along with the genetic, ecological, and anthropogenic factors involved. Examples include the emergence of Ebola from fruit bats, transmission of avian influenza from poultry to humans, and the more recent COVID-19 pandemic, which likely originated from a reservoir of wildlife.
Spillover events are complex processes driven by genetic, ecological, and anthropogenic forces; understanding their mechanisms is essential for detecting, preventing, and managing zoonotic outbreaks [43]. The case studies discussed here provide concrete examples of these dynamics and offer insights for future research and public health strategies. Reducing spillover risk involves a multitude of factors [44]. Knowledge from such studies can inform interventions and enhance community preparedness. Thus, research on viral spillover is critical for safeguarding human health against emerging infectious diseases.
A thorough understanding of spillover mechanisms allows for targeted interventions to reduce outbreak likelihood [45]. For instance, conserving wildlife habitats can limit human–wildlife contact. Similarly, regulating wildlife trade ensures safer handling and transportation. Additionally, developing and deploying effective vaccines against zoonotic viruses is a crucial strategy [46,47]. These efforts, while challenging, are indispensable for protecting public health.
Understanding viral transmission mechanisms between hosts is fundamental. Research over the past thirty years has highlighted key factors [35], including viral characteristics and host factors that influence viral fitness, transmissibility, and zoonotic potential. Successful transmission often depends on viral fitness in a new host, which is shaped by factors like viral load, shedding duration, and viral stability.
This knowledge is crucial for predicting human-to-human transmissions. Examples include HIV-1 and rhinoviruses [48,49]. Viral genetic variation is a key factor in transmissibility and adaptation. RNA viruses such as influenza enter a host with a complex mutant distribution, commonly referred to as viral quasi-species. Therefore, the prediction of host tropism shifts and disease emergence is largely dependent on viral genetic diversity [50]. Transmission pathways include direct and indirect contact, as well as spreading via respiratory droplets, blood, and body fluids. Elucidation of these pathways is essential for designing effective therapeutics and preventive measures [48,51].

3.6. Preventive and Mitigation Strategies

Consequently, a more in-depth understanding of the mechanisms underlying viral transmission will help explain the dynamics of viral zoonoses and the emergence of infectious diseases. Knowledge of viral fitness, genetic variation, and transmission routes is therefore factored into and formulated by researchers to advance strategies for predicting, preventing, and controlling potential public health threats posed by viral infections [43].

4. Host Range and Transmission Dynamics

The capacity of these viruses to adapt to new hosts is essential for cross-species zoonoses. The subsequent chapter details the intricacies of the viral host range, with a particular focus on transmission dynamics and rates governing these processes [52]. Tropism refers to a virus’s predisposition to infect specific host tissues or cells. This occurs through genetic changes, mainly via events such as point mutations and recombination, to enable infection of new hosts [52,53].
Viral tropism is the ability of a virus to infect specific cell types and depends on the presence of specialized receptors on the cell surface [54]. For example, a virus might amass synonymous changes to prepare for host-receptor interaction, even at the cost of viral replication, if it is more important for spreading to new hosts. As a case in point, HIV has evolved to infect human hosts by interacting with the human T-cell surface receptor, CCR5. By taking advantage of this receptor, the virus gains access to human T-cells and eventually kills them, thereby causing AIDS. Such an adaptation is a multistep process, with difficulties arising from the host’s immune defense [50]. Different viruses have a narrow or broad host range, some of which are highly specific, infecting only a few host species. Predictions of virus spread to humans would therefore require knowledge of the molecular mechanisms underlying viral tropism and adaptation [55].
Therefore, studies are required to clarify how a zoonotic virus invades, replicates within, and escapes from new host cells, which is fundamental for understanding the dynamics of transmission. This cycle of attachment, internalization, and release of genetic material. Inside the cell, the virus can replicate its genetic material and produce new viral particles [56,57]. In addition, the viral replication process by which a virus manufactures new copies usually involves viral enzymes that use host cell machinery to synthesize new viral proteins and nucleic acids [58].
Viral shedding refers to the release of a virus from an infected cell. This process occurs via various mechanisms, including cell lysis, exocytosis, and apoptosis [59]. Once a virus successfully enters a new host, it faces the challenge of multiplying and hijacking the host cell’s biology. Viral entry involves attachment to host cell receptors, internalization, and release of viral genetic material into the host cell. Therefore, replication within the host cell permits the production of new viral particles that may be released into the environment and likely cause infection in another host [60]. The efficiency of these processes is highly variable and is predicted to be mediated by factors such as the virus’s genetic compatibility with the host, the host’s immune response, and the presence of co-infections [61]. Such analyses help evaluate the potential for persistent transmission to new host species. Understanding the host range and transmission dynamics of zoonotic viruses is therefore key to developing appropriate prevention and control strategies. A clear understanding of how viruses infiltrate, replicate, and are shed within new hosts, as shown in Table 3, is essential.

5. Immunological Barriers and Evasion

5.1. Innate and Adaptive Immune Responses

When a new virus infects a host, it activates the immune system to mount a defense. This involves both the innate and adaptive immune systems [62]. Recognition of PAMPs commonly found in a variety of pathogens initiates a rapid, but non-specific, innate immune response against infections, which constitutes the first line of defense [63]. In contrast, the adaptive immune response is much more specific and highly selective than the innate immune response, which is activated only by foreign antigens. Antigens are unique molecules present on the surface of pathogens and thus form the basis of adaptive immunity [64]. The adaptive immune response is a long-term response to pathogens. This is due to the formation of memory cells, which respond quickly to secondary infections by the same pathogen [65].

5.2. Genomic Surveillance and Immunological Relevance

These adaptive shifts underscore why genomic surveillance must be prioritized for viruses with high mutation rates. For example, identifying mutations in receptor-binding domains is not only descriptive but has practical significance for predicting increased transmissibility. This interpretation links molecular change directly to public health decision-making [66,67].

5.3. Viral Immune Evasion Strategies

In the immune system, viruses engage in dynamic conflicts against their hosts. This section reviews the host’s immune response against emerging viruses, the different ways viruses evade host immunity, and the main parameters of immunogenetic susceptibility and resistance in the host system [68]. The dynamics of the immune response to viral infection, as noted previously, is a key area of active research and is critical for formulating measures against emerging infectious diseases and virology. This, in turn, affects the design of antiviral treatments and vaccine development [69]. The immune response to viral infection involves a dynamic interplay between the host and the invader (Figure 2). This critically dynamic interplay shapes the outcomes of infectious diseases and guides the pursuit of effective interventions in the complex landscape of virology [62].

5.4. Host Immunogenetics and Susceptibility

A critical factor in susceptibility or resistance to a viral infection is the host’s immunogenetics, which encompasses the genetic factors relevant to the immune system. Genetic polymorphisms in immune-related genes influence responses to viral challenges. More specifically, genes encoding cytokines or MHC molecules harbor polymorphisms which determine an individual’s immune response to a specific virus [70].
This results in a mosaic of immunogenetics in human populations, leading to divergent outcomes during a viral zoonotic event. Therefore, some individuals present an inherent genetic resistance, while others are predisposed to developing severe disease. A better understanding of these genetic elements is needed to identify disparate populations and provide appropriate guidance for vaccination [71].
The dynamic and complex interactions between host immune responses, viral immune evasion strategies, and host immunogenetics determine the outcome of zoonotic viral infections. Viruses have devised multiple strategies to evade immune responses. This continual evasion places persistent selective pressure on the host immune system. Understanding such interactions is justified by the development of new methods that are more effective in preventing and treating viral infections [72]. Despite the challenging and sophisticated research on immunological barriers and means of circumvention, this information remains pivotal to the development of effective strategies to prevent and reverse viral infections. This precise understanding of the intimate interactions of the host immune system could provide a platform for host-targeted therapeutics/antiviral drugs [73].

5.5. Vaccination and Immunotherapy

Increasing vaccine efficacy by developing vaccines that target multiple antigens from the infecting virus remains a focus of research. Multi-epitope targeting is a strategic approach that poses a greater challenge for the virus to evade the host immune response, as shown in Table 4. The fundamental strategy for increasing the efficacy of antiviral drugs is to develop agents that act at multiple stages of the viral replication cycle. This reduces the virus’s capacity to become drug-resistant [74,75]. Finally, governments, in collaboration with stakeholders and public participation, must establish educational programs to educate the public on the importance of vaccination and other protective strategies against viral infections. The public plays a key role in the informed effort against the effects of zoonosis.

6. Genomic Insights into Zoonotic Potential

6.1. Unlocking the Mysteries of Viral Zoonoses Through Comparative Genomics

In studies of viral zoonoses, comparative genomics of viral genomes and their reservoir hosts has proven highly effective. We use comparative genomics to elucidate the genetic determinants underlying host shifts and adaptations, as well as the evolutionary mechanisms that underpin the zoonotic potential of viruses.

6.2. Comparative Genomics of Zoonotic Viruses and Their Reservoirs

This comparative genomic approach analyzes the entire genetic material of zoonotic viruses and their natural hosts to identify genetic signatures that enable viral spillover. For example, entire viral genomes have been sequenced and studied from population samples of different host species to identify genetic alterations responsible for transmission to other species [76]. Comparative genomic studies have highlighted conserved regions within the viral genome that enable the virus to adapt to its host. These studies help predict the zoonotic potential of related viruses and areas where high-risk spillover events may occur. Comparative genomics seeks to understand similarities and differences across species by comparing their genomes to establish evolutionary relationships and identify genetic elements that may affect certain traits [77]. For example, prior work on Ebola virus strains showed that the most virulent strains in humans harbored mutations in genes encoding proteins frequently used for entry and replication [78].
Recent high-throughput sequencing studies of coronaviruses and influenza viruses have revealed recurrent mutation hotspots in receptor-binding domains. These mutations alter binding efficiency and host range, highlighting key mechanisms of adaptation. Comparative analyses further show that recombination between divergent strains accelerates cross-species transmission potential. Such insights not only describe but also identify specific genomic signals that must be monitored in real time for early warning systems [79].

6.3. Genetic Determinants of Host Switching and Adaptation

Host switching and adaptation are complex processes that depend on genetic changes in the virus. Mutations in viral genes encoding surface proteins, such as the spike protein in coronaviruses, can alter host receptor recognition and tropism, allowing the virus to infect new species. Recombination can also result in hybrid viruses with a unique host range [50,80]. Understanding the genetic determinants that underlie host-switching and adaptation is central to assessing the risk of zoonotic outbreaks, providing insight into a virus’s ability to infect humans or other species and guiding surveillance efforts and proactive preparedness measures [81,82].
These processes reveal convergence across viral families. For example, receptor-binding adaptations in coronaviruses and influenza can follow parallel routes, suggesting predictable evolutionary strategies. Recognizing these convergences enables us to prioritize specific genomic signatures for surveillance, moving beyond descriptive mutation lists [83].
Machine learning-based tools are now applied to genomic datasets to predict which mutations are most likely to increase zoonotic potential. These computational models integrate structural biology with sequence evolution, enabling the prioritization of variants with higher risk. Embedding these approaches in global databases creates operational pathways for cross-border genomic surveillance [83,84].
Recent genomic analyses of SARS-CoV-2 variants demonstrated that mutations in the receptor-binding domain of the spike protein altered affinity for the ACE2 receptor, increasing transmissibility and reshaping pandemic dynamics [85,86]. Similar findings in avian influenza A viruses showed that reassortment events affecting hemagglutinin and neuraminidase genes can generate strains with enhanced zoonotic potential. Comparative genomics thus provides a predictive framework for identifying viral lineages capable of crossing species barriers and informs surveillance strategies that prioritize high-risk mutations [87].

6.4. Host Switching and Adaptation

Host switching refers to a change in a virus’s host range, in which it establishes infection in a new host species. In contrast, adaptation refers to the evolution of a virus that optimizes its fitness and transmission in a new host species [88]. More specifically, many genetic features are involved in host switching and adaptation, such as mutations in genes encoding proteins that enable viral entry and replication, allowing the virus to bind to new receptors and replicate in other cell types [89,90]. During gene acquisition, viruses can acquire new genes that confer traits to themselves or their hosts. This includes infection of new host species and evasion of the host immune system [91]. There are also differences in their gene expression; viruses modulate gene expression. They use different environmental signals to adapt to other host species and to various stages of the infection cycle [92]. Comparative genomics in viral zoonosis research provides insights into the basic mechanisms underlying these pathogens.
This provides clues for possible pathways for early detection and targeted prevention strategies. Comparative genomics reveals how specific adaptive pathways are favored under ecological constraints. For instance, host-switching events often converge on similar receptor-binding adaptations across unrelated viral families, suggesting predictable evolutionary routes. Recognizing these convergences allows risk models to focus on specific genetic signatures rather than broad descriptive categories [93].
Recent work has shown that zoonotic RNA viruses often exist as quasi-species, meaning they replicate as diverse populations of closely related variants within a host. This intra-host diversity enables rapid adaptation to selective pressures, such as immune responses or therapeutic interventions. Identifying these quasi-species dynamics is critical because minor variants often seed successful cross-species transmissions [94,95].

6.5. Evolutionary Dynamics of Zoonotic Viruses

The evolutionary history of zoonotic viruses is shaped by adaptation, divergence, and spillover. Sequencing viral genomes in the context of evolutionary dynamics has enabled scientists to reconstruct the origins of zoonotic viruses and trace the hosts they infect [92]. Among broad genomic studies on zoonoses, phylogenetic analyses are another tool that reveals relationships with their natural counterparts. Such investigations have revealed the roots of outbreaks and shed light on the enduring evolutionary strategies of zoonotic viruses. A critical analysis of these strategies shows both opportunities and limits. While phylogenomic tracing has improved the resolution of outbreak origins, analytical gaps remain in linking sequence data to ecological drivers. Future work must bridge this divide by integrating genomic signals with host ecology, land-use patterns, and trade networks.
In summary, genomics has revolutionized our understanding of viral zoonoses by illuminating the genetic details of host switching, adaptation, and evolution [96]. Comparative genomics will therefore be highly informative about potential hotspots of zoonotic spillover, genetic determinants of host switching, and evolutionary drivers of new zoonotic threats. These results could be valuable for preparedness, surveillance, and risk-mitigation strategies [97].
Recombination hotspots in coronaviruses and influenza viruses have been mapped with increasing precision, revealing loci where genetic exchange accelerates adaptation to new hosts. In parallel, advances in phylogenomic tools now allow near real-time reconstruction of outbreak origins and transmission chains. For example, platforms that integrate whole-genome data with ecological and epidemiological metadata can pinpoint animal reservoirs and high-risk spillover interfaces with greater resolution than traditional phylogenetics [83,95].

6.6. Evolutionary Dynamics and Influencing Factors: Navigating the Genomic Seas

Viruses exhibit efficient adaptive strategies to new host environments through mutations and recombination. Zoonotic viruses constantly evolve within the reservoir host, a process that continues when crossing a species barrier [97]. A myriad of factors influence their evolutionary processes, broadly categorized into selection pressure by the host’s immune system, genetic drift, and recombination.
The host immune system exerts intense selective pressure on zoonotic viruses, driving the emergence of strains that evade immune responses. This is a clear example of the ongoing evolutionary race between the host and the pathogen of interest [98,99]. Genetic drift also plays a considerable role. As a stochastic process, it causes alterations in allele frequencies across viral populations. For most zoonotic viruses, population sizes especially given the large population sizes, random events strongly affect their genetic diversity [100]. Finally, zoonotic viruses undergo recombination. This central recombination mechanism generates new viral sequences often with novel traits unattainable through mutation alone. This facilitates continuous reshuffling of viral genomes [83]. The interplay of these evolutionary forces shapes the trajectory of zoonotic viruses. A comprehensive understanding of these evolutionary processes is necessary to develop appropriate disease management and prevention [101].
Recent genomic studies have expanded our understanding of zoonotic potential. For instance, analyses of SARS-CoV-2 variants demonstrated that mutations in the spike protein enhanced affinity for the human ACE2 receptor, increasing transmissibility and shaping pandemic dynamics [18,86,102]. Similarly, surveillance of avian influenza A viruses has shown how reassortment events can produce strains with higher pandemic potential, underscoring the role of genetic plasticity in spillover [30,31]. These findings highlight how comparative genomics and predictive modeling are now indispensable tools for anticipating zoonotic threats.

7. Applications for Genomic Insights

7.1. Utilizing Advanced Technologies for Zoonotic Insights

The fast-growing, genomic cutting-edge technologies, such as next-generation sequencing, have revolutionized our understanding of zoonotic diseases. This provides new insight into the delicate relationship between the forces of evolution and transmission that characterize zoonotic diseases [103]. The development of robust, state-of-the-art disease surveillance systems is important for advancing genomic knowledge. Accordingly, monitoring the genetic drift of these viruses could help identify new threats and develop early warning systems for potential outbreaks, thereby preventing the insidious rise in infectious diseases [104].
Another primary targeted application of the knowledge gained from this information is the development of urgently needed vaccines and antiviral therapeutics. These studies have focused on explicit genetic determinants closely linked to host switching and adaptation, from which we may be able to design vaccines and antiviral drugs that are more effective against a broad range of zoonotic viruses. This precision-guided approach enriches the armament against ever-adapting viral adversaries [105]. Public education is the last and most important factor in the symphony of prevention, creating more awareness about the existence of zoonotic diseases and knowledge of safety measures, avoiding wild animals, and cooking wild animals properly, as shown in Table 5; hence, it is a different major defense force among people in the community [105].

7.2. Defense Strategies for Predicting and Preventing Zoonotic Events

The prevention of infectious diseases is not possible without the prediction and prevention of zoonotic events. This section has discussed major elements of strategies and methodologies for forecasting and preventing zoonotic events, primarily through surveillance and early warning systems or through a holistic approach, such as One Health [106]. Prediction and prevention of zoonotic transmission are central to combating emerging infectious diseases. This section provides an in-depth analysis of leading strategies, emphasizing surveillance mechanisms, early warning protocols, and the integrative One Health framework [97].

7.3. Viral Monitoring Strategies

Surveillance, the sentinel at the ramparts, alerts us to our forts. Surveillance is the cornerstone for forecasting and prevention. Comprehensive monitoring of viruses in wildlife reservoirs may serve as a source of zoonotic infections. Human surveillance focuses on closely linked reports, mainly on cases of uncommon diseases and clusters of unknown etiology [29,107]. Modern methodologies have primarily relied on the polymerase chain reaction (PCR) and next-generation sequencing, revolutionizing molecular processes in viral surveillance. This method quickly identifies and characterizes viruses from animals to humans. Therefore, continuous monitoring provides an early indication of the potential spillover events. Surveillance remains vital for estimating and preventing these zoonotic diseases and for continuous tracking of populations for disease presence [108,109].
Conversely, wildlife viral surveillance focuses on zoonotic viruses in animal populations. This has been conducted by collecting and analyzing various biological samples from wildlife, including blood, saliva, and feces [97]. Viral surveillance from humans through biological specimens such as blood, urine, and respiratory samples can detect zoonotic viruses that spill over into humans [110]. Expecting and proactively preventing such zoonotic events are crucial for combating EIDs. These means of surveillance have advanced modern technologies, paving the way for rapid detection and prompt responses to protect wildlife and human populations from the risks of zoonotic diseases [97].

7.4. Predictive Modeling and Early Warning for Zoonotic Diseases

Establishing early warning systems has become the tool of choice for timely interventions to avoid potential zoonotic events. Early warning systems use predictive models to estimate the likelihood of a prospective zoonotic event, based on surveillance data. Models require information about host populations, ecological changes, and viral genetics to predict the possibility of spillover events [104,111]. These systems are designed to identify high-risk interfaces and their drivers.
The dynamically changing environment means that machine learning and artificial intelligence combine to enhance predictive models with greater accuracy in real time, enabling risk assessment. For example, it is possible to monitor the increased prevalence of zoonotic viruses in wildlife and the human population, thereby identifying high-risk geographical areas [112].

7.5. One Health Approach

The One Health approach fundamentally recognizes that human, animal, and environmental health are interconnected; it involves interdisciplinary collaborations across disciplines, such as virologists, epidemiologists, ecologists, and veterinarians [113]. As the One Health approach is multidisciplinary, many scientists and policymakers are seeking to understand the drivers of changes in zoonotic disease incidence. The Rift Valley fever outbreaks in East Africa highlighted the value of joint human–animal surveillance programs that linked veterinary services with public health laboratories. Similarly, H5N1 avian influenza control in Southeast Asia demonstrated how coordinated animal culling, trade restrictions, and environmental monitoring can reduce spillover risk when sectors work together [114,115].
This encompasses how changes in land use and climate affect the spread of zoonotic pathogens driven by these environmental changes. This approach advocates not only health but also conservation and sustainability [116]. Zoonosis control calls for surveillance and prevention strategies that support early warning systems and integrate human, animal, and environmental health approaches. Such programs should be designed to prevent spillover before it occurs, identify early warning signs, and act with targeted preventive measures to protect public health and ecosystems [97].
This has been proven to be of utmost importance for predicting and preventing zoonotic events. It can identify potential risk-based intervention opportunities by integrating data from the human, animal, and environmental health sectors to advance practical, effective prevention and control approaches [117]. Undoubtedly, predicting and preventing zoonotic events are uphill tasks. However, significant progress can be made with surveillance techniques, advanced warning systems, predictive models, and the One Health approach [118]. The high-yield areas of future research include developing improved methodologies for surveillance and developing early warning and prediction models [119]. Recent technologies involving artificial intelligence and machine learning have the potential to revolutionize the capabilities of different stakeholders in zoonotic event prediction and discrimination [120]. These technologies can integrate diverse data streams to identify patterns that would otherwise remain obscured.

8. Case Studies of Notable Zoonotic Outbreaks

8.1. Ebola Virus Disease: Spillover from Bats to Humans

Ebola virus disease (EVD) is an example of the consequences of zoonotic spillover events. The virus originated in bats, which transmit the infection to humans through direct or indirect contact with an infected bat or its bodily fluids. The West African outbreak of 2014–2016 epitomized this destructive capability, prompting international efforts to improve surveillance and healthcare infrastructure, as well as the development of more effective vaccines. Indeed, the number of cases (>28,000), resulting in more than 11,000 deaths, strongly supports the need for improved disease control measures in the African region [121,122]. The high fatality rate and rapid spread during this outbreak highlighted the critical need for robust global health security systems.

8.2. Avian Influenza: Transmission from Birds to Humans

Avian influenza has crossed the species barrier and is a global concern. It is caused by avian influenza A viruses, such as H5N1 and H7N9. The main transmission route is through close contact with infected birds or contaminated environments [123]. Although human-to-human spread remains limited, the potential for this virus to adapt and improve transmissibility in the future is a significant threat. This pandemic potential drives ongoing research and preparedness efforts. Vigilant farm surveillance, early detection, and rapid response are essential to prevent poultry outbreaks. The H5N1 outbreak in 2003 sparked public concern, leading to the development of vaccines and antivirals. The virus has persisted in avian populations ever since and thus remains a potential threat [124].

8.3. COVID-19: Emergence of SARS-CoV-2 and Its Global Impact

SARS-CoV-2, the coronavirus, has turned the world on its head through the COVID-19 pandemic within months of its emergence. Thought to have initially emerged in wildlife, with bats and potentially pangolins as intermediate hosts, the virus has spread in the human population (Figure 3), quickly becoming a global public health concern and prompting vaccine development. Its rapid global spread underscored the profound threat of zoonotic pathogens with high transmissibility. The pandemic has exposed health systems’ fragilities, fissures in economic inequality, and the extent to which the world has been interdependent [125,126,127]. Genomic characterization of SARS-CoV-2 has deepened our understanding of the virus’s evolutionary and adaptive processes in humans, thereby highlighting the urgent need for international collaboration in data sharing and preparedness for the management of emerging infectious disease outbreaks [128].
A comparative analysis of Ebola, avian influenza, and COVID-19 outbreaks highlights divergent pathways of zoonotic emergence. Ebola represents direct wildlife-to-human spillover with limited sustained transmission, while avian influenza shows partial adaptation without efficient human-to-human spread. COVID-19, in contrast, demonstrates complete adaptation with rapid global dissemination. These differences reveal that surveillance and interventions must be tailored to the specific genomic and ecological drivers of each virus [129]. Ebola underscores the limits of containment when health systems are weak, avian influenza illustrates the persistent risk of reassortment, and COVID-19 shows how rapid viral evolution combined with global connectivity can trigger a pandemic. This comparative perspective turns familiar outbreaks into evidence for differentiated strategies, such as prioritizing real-time genomic monitoring for high-mutation RNA viruses and ecological interventions for viruses with constrained adaptation [130].
These case studies also highlight ongoing controversies. Some scholars argue that genomic surveillance alone provides sufficient early warning, while others contend that ecological interventions at the animal–human interface are equally critical. The debate reflects a lack of consensus on whether investment should prioritize laboratory genomics or broader ecological and social prevention measures [131].
These are poignant reminders of the multifaceted dynamics. The need for surveillance and early detection, as well as a strategic response, has been shown to prevent and reduce the impact of upcoming zoonotic events. COVID-19 was, in many senses, a lesson that the world should invest in as a policy in scientific research to potentially design new vaccines and treatments in the future [132]. The pandemic served as a stark catalyst, proving that sustained investment in scientific research is non-negotiable for developing future countermeasures.
Therefore, the strategic deployment of resources in zoonotic studies is critical, as a better understanding of their origins and transmission can lead to more effective control and prevention measures, as shown in Table 6. A more robust One Health approach is imperative for diminishing the risk of the next zoonotic outbreak [133]. Finally, public education regarding the dangers of these diseases and the steps that can be taken to prevent them is important. This concerted effort underscores the strong need for collaborative efforts to safeguard global health and well-being [134].

9. Interventions and Mitigation Strategies

9.1. Vaccination as a Preventive Measure

Prophylaxis and vaccination are fundamental pillars for the prevention and, when possible, the control of zoonoses. The forward deployment of vaccines to target new zoonotic pathogens represents an optimal strategy for preventing infectious diseases. These vaccines induce protective immune responses that limit disease severity and transmission [135,136,137].
Although vaccines are available for a few zoonotic diseases, such as rabies, yellow fever, Japanese encephalitis, and hepatitis A, one must remember that many other diseases do not have vaccines readily available. The massive worldwide push to develop and use COVID-19 vaccines exemplifies the power of emerging technologies, including mRNA vaccines. The success of mRNA platforms demonstrates a promising path for rapid vaccine development against future emerging threats. High-priority groups should receive vaccination first, with the necessary goal of building immunity within the population [138,139].

9.2. Antiviral Treatments: Targeted Solutions for Viral Infections

Antiviral drugs have a crucial role in treating zoonotic outbreaks. These drugs are usually specific and target selected proteins or processes responsible for the viral replication cycle that leads to illness. Moreover, drug repurposing during the early stages of an outbreak can provide a rapid alternative to established medications for these cases, as seen during the early phases of the COVID-19 pandemic [138,140,141]. This approach can buy critical time until more specific therapeutics are developed. Similarly, research on novel antiviral treatments targeting the specific properties of zoonotic viruses is underway. Such therapeutic measures may drastically reduce mortality rates and the overall burden of zoonotic diseases [142,143].

9.3. Quarantine and Containment Measures

Quarantine and containment remain central strategies for constraining the spread of zoonoses during outbreaks. Containment initiatives usually involve contact tracing, isolating patients diagnosed with the disease, implementing travel restrictions, and enforcing social distancing, among other public health measures. These measures are designed to break chains of transmission [144,145].
They depend on early identification, swift responses, and active community participation. Past outbreaks, such as the 2014 Ebola epidemic and the COVID-19 pandemic, underscore the pivotal role of quarantine and containment measures. However, their success is closely linked to a robust healthcare infrastructure, public health readiness, and transparent communication [146]. A comprehensive defense against zoonotic threats will probably require a holistic approach, including vaccination, antiviral treatment, and efficient quarantine and containment measures, which might lower the disease burden, curtail transmission, and safeguard public health. Appropriately applying these strategies at the right time, along with promoting further research to improve the effectiveness of the approaches, remains paramount in the fight against this emerging zoonotic disease [147].

10. Ethical and Societal Implications

The upsurge in zoonotic diseases poses challenging ethical issues at the confluence of concerns for human health, conservation imperatives, and animal welfare. An integral part of biodiversity conservation is accounting for animal welfare and the health risks animals pose to humans through close contact. The One Health approach, urging nations to fully grasp the interconnections among health, animals, and ecosystems, has become an essential tool for navigating these complex trade-offs [106,113,118]. This framework helps balance the need to protect human populations with the ethical obligation to preserve biodiversity and ensure animal welfare.

10.1. Ethical Considerations in a One-Health Approach

During the 2014–2016 Ebola outbreak in West Africa, bushmeat bans reduced spillover risk but raised ethical dilemmas by threatening food security and cultural traditions. Similarly, during the COVID-19 vaccine rollout, inequities between high- and low-income countries highlighted societal challenges to health justice. These cases demonstrate why ethical principles cannot remain abstract but must be applied to specific policy decisions [148]. The One-Health approach integrates human, animal, and environmental health and raises several ethical considerations that need to be addressed when facing a zoonotic spillover, these include, but are not limited to:
  • Arriving at a proper balance between these competing priorities means that ethical considerations must be taken into account.
  • Minimizing Harm to Wildlife: Practicing conservation so that minimal harm is done to wildlife while considering the possible consequences of the interventions on the ecosystem and the health of animal populations.
  • Safeguarding Ecosystems and ensuring environmental welfare: Ecosystems must be preserved through conservation efforts because of their intrinsic value and the integrity of species interactions.
  • Ensuring the Welfare of Local Communities: Ethical principles require attention to the welfare of local communities, including indigenous communities. Engagement with these community stakeholders goes a long way toward a policy that ideally meets ethical standards.
  • Interdisciplinary collaborations among the various fields and disciplines (Human medicine, veterinary medicine, microbiology, wildlife biology, etc.) are required, as well as addressing ethical challenges to ensure respect for each field and effective communication and transparency, as shown in Table 7.

10.2. Impact of the Interventions on Multiple Stakeholders

Ethical challenges often arise from potential conflicts between interventions and their impacts on stakeholders. For example, although quarantine and containment measures can effectively halt zoonotic transmission, adverse effects on wildlife conservation and animal welfare must be carefully considered. Measures like culling can control disease but raise significant ethical dilemmas. Decision-makers must assess the impact of these interventions on all stakeholders [149].

10.3. Cultural Practices and Zoonotic Risks

Cultural practices and behaviors significantly influence the risk of zoonotic spillover. Activities such as hunting bushmeat, participating in the wildlife trade, and relying on traditional medicine can bring humans into close contact with potential reservoirs of zoonotic pathogens. Cultural rituals involving wildlife consumption may pose risks, especially in regions where zoonotic diseases are prevalent [150,151].

10.4. Cultural Sensitivity and Community Engagement

The response to these challenges must be approached through cultural sensitivity and active community engagement. The key considerations include the following:
  • Reinforce Cultural Diversity: Any comprehensive strategy to reduce zoonotic risks should respect and honor cultural diversity, affirming the value of traditional practices.
  • Active Community Engagement: Active interaction with communities and their involvement in aspects related to the public helps ensure mutual understanding and safer practices are in place. Localized public health education campaigns work well when tailored to local communication channels and, hence, serve as a good tool for raising awareness of zoonoses within cultural norms.

10.5. Lessons Learned and Recommendations for the Future

Zoonotic diseases represent a significant threat to global health. This led to a clarion call for transdisciplinary collaboration among professionals in human, animal, and environmental health. Surveillance and data sharing for prioritized zoonotic diseases, improved laboratory testing, and other joint capacity-building in the human and animal health sectors aim to establish robust mechanisms for detecting and responding effectively to emerging health threats, thereby increasing global health security [152].
Zoonotic diseases threaten humans and animals [153]. However, recent epidemics have negatively affected the economy on a large scale. The Member States of ECOWAS adopted a list of seven priority zoonotic diseases in the region, namely Anthrax, Rabies, Ebola, and other viral hemorrhagic fevers (VHFs), zoonotic influenzas, zoonotic tuberculosis, Trypanosomiasis, and Yellow fever [154].
The increasingly interconnected human–animal interface has led to an alarming and unprecedented rise in zoonotic infections. In Uganda, a multisectoral health zoonotic disease prioritization workshop platform identified the following seven zoonoses in 2017 as priority zoonotic diseases: anthrax, zoonotic influenza, viral hemorrhagic fevers, brucellosis, trypanosomiasis, and plague [155]. The practical lesson from recent outbreaks is that success depends not only on transdisciplinary collaboration but on how quickly genomic evidence is integrated into decision-making. Data-sharing platforms such as GISAID have shown that open genomic surveillance can directly inform containment, an approach that should be extended to neglected zoonoses [156]. This integration is critical for transitioning from reactive responses to proactive, intelligence-driven prevention.

10.6. Education and Communication

Education and communication are essential components of zoonotic disease prevention and control. Culturally sensitive and transparent public health education strategies are vital for building informed communities that can embrace behaviors that promote safety. Effective communication and education have been emphasized in lessons from past outbreaks, such as those caused by Nipah, Ebola, and COVID-19. This could be achieved by developing public information strategies on the incidence of zoonotic diseases and their mitigation, through coordinated actions by the government, international organizations, research institutions, and community stakeholders [157,158]. Separately, promoting sustainable land use is a critical preventive measure, as it limits human encroachment into undisturbed habitats and thereby reduces spillover opportunities. Another critical component of a proactive approach to zoonotic disease prevention is investing in pandemic preparedness, which includes developing medical countermeasures, improving healthcare infrastructure, and conducting simulations [159].

10.7. Emerging Ethical Challenges

Zoonotic outbreaks have significant ethical and societal implications and therefore require an integrated, multisectoral response that strategically balances the priorities of human health, conservation, and animal welfare. Effective control of zoonotic outbreaks is possible only with an approach that involves appropriate multidisciplinary expertise, forensic pathologists, and experts, and the communication of findings to enable timely diagnosis, detection, and emergency response [160].
The emerging threat of zoonotic orthopoxvirus infections is one example of the need for international coordination to prevent outbreaks from escalating into epidemics [161]. Identifying priority zoonoses through a One Health approach, as in Jordan’s experience, guides political decisions on these threats to health and other involved sector stakeholders [153]. Therefore, it is necessary to understand the characteristics of zoonotic disease outbreaks and quantify the relationships between drivers of outbreaks and their severity to inform well-crafted surveillance and prevention strategies. A One Health approach must be collaboratively employed for zoonotic pathogens with epidemic potential, as demonstrated with the Middle East respiratory syndrome coronavirus [162].
The COVID-19 pandemic is a poignant reminder that the devastating impacts of a zoonotic disease demand preemptive, coordinated efforts. To be effective, control efforts in Africa and beyond must be grounded in the One Health approach to prevent and detect outbreaks early. There should be enhanced coordination and collaboration mechanisms, grounded in the One Health approach, to effectively control zoonotic diseases in Africa, with negligible economic and health impacts from outbreaks. Improving inter-organizational collaboration for wildlife disease surveillance enhances the capacity to quickly detect and respond to zoonotic disease outbreaks in countries such as Sri Lanka [163]. Similarly, rapid detection and response to zoonotic threats would significantly facilitate the operationalization of One Health in India, thereby minimizing their effects [164].
In summary, global zoonotic research networks are essential for understanding the interactions of people, animals, and ecosystems in managing and controlling zoonotic disease risks and outbreaks. The economic impacts of zoonosis outbreaks underscore the importance of One Health in fighting zoonoses and ensuring food safety. Robust, collaborative surveillance systems are critical for providing early warning of zoonotic infections, enabling effective disease response and control. Robust, collaborative surveillance systems are critical for providing early warning of zoonotic infections, enabling effective disease response and control [165].

10.8. Lessons from the COVID-19 Pandemic

Zoonoses should be anticipated and preempted to ensure the effectiveness of approaches to emerging infectious diseases. Lessons from COVID-19 should, in this regard, draw significant attention to greater investment in research and development to better understand zoonotic diseases and develop customized prevention and control strategies. The One Health approach is highly relevant in this respect [166].
Such information needs to be integrated into these domains to detect possible zoonotic transmission risks. The One Health approach demands interdisciplinary collaboration among human healthcare providers, veterinarians, and environmental scientists, and the optimization of integrated surveillance systems to detect zoonotic diseases early in wildlife and human populations. Further, interventions must be designed to be cost-effective, efficient, and equitable for all populations.
Culturally sensitive community involvement programs that are cost-effective in encouraging hand hygiene will yield safer practices and reduce the threats of zoonotic transmission. Together, they will improve our readiness and response to zoonotic threats, thereby maintaining public health safety across multiple fronts [106]. Finally, combating zoonotic diseases requires a multi-pronged approach that includes research, partnerships, fairness, and community involvement. Implementing these recommendations, together with the One Health perspective, will strengthen the prevention and control of zoonoses for public and ecological well-being.

11. Conclusions

Zoonotic viruses represent one of the most persistent threats to global health security because their genomic plasticity allows them to adapt under ecological and anthropogenic pressures. The comparative evidence reviewed here demonstrates that spillover risk is not random but shaped by predictable genomic determinants such as mutation hotspots, recombination events, and quasi-species dynamics. These processes interact with ecological drivers, including land-use change, wildlife trade, and climate disruption, creating conditions that favor viral adaptation and cross-species transmission.
From a governance perspective, the COVID-19 pandemic underscored both the strengths and weaknesses of global genomic surveillance. While platforms such as GISAID enabled rapid tracking of variants, neglected zoonoses in resource-limited regions remain underrepresented in genomic datasets. This imbalance limits accurate global risk assessment and highlights a key area for international cooperation.
Future progress requires integrating genomic data into actionable One Health strategies. This includes linking sequence monitoring with ecological surveillance, embedding machine learning tools for early warning, and addressing inequities in data access and public health infrastructure. Research should also prioritize underexplored zoonoses beyond coronaviruses and influenza, as these pathogens pose significant but less visible risks.
In summary, the relevance of genomics lies not in descriptive cataloguing of viral changes but in how these insights reshape preparedness. By situating genomic evidence within ecological and societal contexts, we can move from reactive responses toward proactive systems capable of anticipating zoonotic emergence.
Despite progress, important knowledge gaps remain. Climate-driven changes in reservoir and vector distribution are insufficiently integrated into zoonotic models. Antimicrobial resistance, though often considered separately, is emerging as a compounding factor in zoonotic outbreaks. Research on neglected pathogens, such as Rift Valley fever and Lassa fever, also lags behind that of influenza and coronaviruses, leaving high-risk regions underrepresented in global data.

12. Future Research Directions and Critical Gaps

While progress has been made, significant gaps remain. Climate-driven shifts in reservoir and vector distribution are underexplored in the context of zoonotic risk. Integrating climate models with genomic surveillance could improve predictive power. Ethical dilemmas also persist, particularly when interventions require wildlife population management or restrictions on cultural practices involving animal use. Another critical gap is the uneven distribution of genomic and surveillance resources, which leaves high-risk regions underrepresented. Addressing these issues requires coordinated global investment, interdisciplinary collaboration, and the development of cost-effective approaches tailored to resource-limited settings.
Unresolved questions persist. How can ethical wildlife interventions be balanced with urgent public health measures when spillover risk is high? What are the most effective models for integrating human, animal, and environmental data across diverse settings? These remain open issues requiring interdisciplinary dialogue and policy innovation.
A critical issue is the disparity between well-studied pathogens, such as influenza and coronaviruses, and neglected zoonoses, such as Rift Valley fever and Lassa fever, which pose equally severe risks in endemic regions. Research has been unevenly distributed, with high-income countries benefiting from genomic surveillance while low-resource regions remain data-poor. This gap hampers accurate global risk assessment. Addressing this imbalance should be a priority for international agencies. Another underexplored area is the potential role of antimicrobial resistance as a compounding factor in zoonotic outbreaks, which warrants systematic study.

Author Contributions

A.A.A.A., R.M.B., R.A., E.Q., O.G., A.A., V.M., Y.M., M.E.-T. and T.H. contributed equally to this work. A.A.A.A. was responsible for the conceptualization and writing of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

The research was funded by the deanship of scientific research, Yarmouk University, grant number 1/2024.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Luis, A.D.; Hayman, D.T.S.; O’Shea, T.J.; Cryan, P.M.; Gilbert, A.T.; Pulliam, J.R.C.; Mills, J.N.; Timonin, M.E.; Willis, C.K.R.; Cunningham, A.A.; et al. A Comparison of Bats and Rodents as Reservoirs of Zoonotic Viruses: Are Bats Special? Proc. R. Soc. B Biol. Sci. 2013, 280, 20122753. [Google Scholar] [CrossRef]
  2. Recht, J.; Schuenemann, V.J.; Sánchez-Villagra, M.R. Host Diversity and Origin of Zoonoses: The Ancient and the New. Animals 2020, 10, 1672. [Google Scholar] [CrossRef]
  3. Taylor, L.H.; Latham, S.M.; Woolhouse, M. Risk Factors for Human Disease Emergence. Philos. Trans. R. Soc. B Biol. Sci. 2001, 356, 983–989. [Google Scholar] [CrossRef]
  4. Newmana, H.; Abrahamsb, S. Zoonotic Viral Infections in South Africa: An Overview. Res. Rev. Insights 2018, 2, 1–7. [Google Scholar] [CrossRef]
  5. Walker, J.; Han, B.A.; Ott, I.M.; Drake, J.M. Transmissibility of Emerging Viral Zoonoses. PLoS ONE 2018, 13, e0206926. [Google Scholar] [CrossRef]
  6. Allen, L.J.S.; Brown, V.L.; Jonsson, C.B.; Klein, S.L.; Laverty, S.M.; Magwedere, K.; Owen, J.C.; Driessche, P.V.D. Mathematical Modeling of Viral Zoonoses in Wildlife. Nat. Resour. Model. 2011, 25, 5–51. [Google Scholar] [CrossRef] [PubMed]
  7. Johnson, C.K.; Hitchens, P.L.; Evans, T.S.; Goldstein, T.; Thomas, K.; Clements, A.; Joly, D.O.; Wolfe, N.; Daszak, P.; Karesh, W.B.; et al. Spillover and Pandemic Properties of Zoonotic Viruses With High Host Plasticity. Sci. Rep. 2015, 5, 14830. [Google Scholar] [CrossRef] [PubMed]
  8. Grewelle, R.E. Larger Viral Genome Size Facilitates Emergence of Zoonotic Diseases. bioRxiv 2020. [Google Scholar] [CrossRef]
  9. Singh, B.B.; Ward, M.P.; Dhand, N.K. Inherent Virus Characteristics and Host Range Drive the Zoonotic and Emerging Potential of Viruses. Transbound. Emerg. Dis. 2021, 69, e799–e813. [Google Scholar] [CrossRef]
  10. Richard, M.; Graaf, M.d.; Herfst, S. Avian Influenza a Viruses: From Zoonosis to Pandemic. Future Virol. 2014, 9, 513–524. [Google Scholar] [CrossRef]
  11. Eng, C.L.P.; Tong, J.C.; Tan, T.W. Predicting Zoonotic Risk of Influenza a Viruses From Host Tropism Protein Signature Using Random Forest. Int. J. Mol. Sci. 2017, 18, 1135. [Google Scholar] [CrossRef]
  12. Skivington, K.; Matthews, L.; Simpson, S.A.; Craig, P.; Baird, J.; Blazeby, J.M.; Boyd, K.A.; Craig, N.; French, D.P.; McIntosh, E.; et al. A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance. Br. Med. J. 2021, 374, n2061. [Google Scholar] [CrossRef]
  13. Fatima, M.; An, T.; Park, P.G.; Hong, K.J. Advancements and Challenges in Addressing Zoonotic Viral Infections with Epidemic and Pandemic Threats. Viruses 2025, 17, 352. [Google Scholar] [CrossRef]
  14. Thien, D.H.; Tran, H.B.; Uyen, N.N.P.; Thao, H.L.P.; Tam, H.; Quan, N.K.; Huy, N.T. A comprehensive review of Langya virus and framework for future zoonotic disease control. Rev. Med. Virol. 2024, 34, e2520. [Google Scholar] [CrossRef]
  15. Mishra, V.; Bankar, N.; Tiwari, A.; Noman, O.; Bandre, G. Emerging Zoonotic Viral Diseases in India: One Health Perspective. J. Pure Appl. Microbiol. 2025, 19, 34. [Google Scholar] [CrossRef]
  16. Villarroel, P.M.S.; Gumpangseth, N.; Songhong, T.; Yainoy, S.; Monteil, A.; Leaungwutiwong, P.; Misse, D.; Wichit, S. Emerging and re-emerging zoonotic viral diseases in Southeast Asia: One Health challenge. Front. Public Health 2023, 11, 1141483. [Google Scholar] [CrossRef]
  17. Anil, S.; Joseph, B.; Thomas, M.; Sweety, V.K.; Suresh, N.; Waltimo, T. Monkeypox: A Viral Zoonotic Disease of Rising Global Concern. Infect. Dis. Immun. 2024, 4, 121–131. [Google Scholar] [CrossRef]
  18. Guth, S.; Visher, E.; Boots, M.; Brook, C.E. Host Phylogenetic Distance Drives Trends in Virus Virulence and Transmissibility Across the Animal–human Interface. Philos. Trans. R. Soc. B Biol. Sci. 2019, 374, 20190296. [Google Scholar] [CrossRef] [PubMed]
  19. Fisher, M.C.; Murray, K.A. Emerging Infections and the Integrative Environment-Health Sciences: The Road Ahead. Nat. Rev. Microbiol. 2021, 19, 133–135. [Google Scholar] [CrossRef] [PubMed]
  20. Brook, C.E.; Rozins, C.; Guth, S.; Boots, M. Reservoir Host Immunology and Life History Shape Virulence Evolution in Zoonotic Viruses. PLoS Biol. 2023, 21, e3002268. [Google Scholar] [CrossRef]
  21. Mollentze, N.; Streicker, D.G. Viral Zoonotic Risk Is Homogenous Among Taxonomic Orders of Mammalian and Avian Reservoir Hosts. Proc. Natl. Acad. Sci. USA 2020, 117, 9423–9430. [Google Scholar] [CrossRef] [PubMed]
  22. Guth, S.; Mollentze, N.; Renault, K.; Streicker, D.G.; Visher, E.; Boots, M.; Brook, C.E. Bats Host the Most Virulent—But Not the Most Dangerous—Zoonotic Viruses. Proc. Natl. Acad. Sci. USA 2022, 119, e2113628119. [Google Scholar] [CrossRef]
  23. Turmelle, A.S.; Olival, K.J. Correlates of Viral Richness in Bats (Order Chiroptera). Ecohealth 2009, 6, 522–539. [Google Scholar] [CrossRef]
  24. Jelinek, H.F.; Mousa, M.; Alefishat, E.; Osman, W.; Spence, I.; Bu, D.; Feng, S.F.; Byrd, J.; Magni, P.A.; Sahibzada, S.; et al. Corrigendum: Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review. Front. Vet. Sci. 2023, 10, 1147940. [Google Scholar] [CrossRef]
  25. Glud, H.A.; George, S.; Skovgaard, K.; Larsen, L.E. Zoonotic and Reverse Zoonotic Transmission of Viruses Between Humans and Pigs. Apmis 2021, 129, 675–693. [Google Scholar] [CrossRef]
  26. Hsu, T.H.; Spindler, K.R. Identifying host factors that regulate viral infection. PLoS Pathog. 2012, 8, e1002772. [Google Scholar] [CrossRef]
  27. Davidson, A.D.; Williamson, M.K.; Lewis, S.; Shoemark, D.; Carroll, M.W.; Heesom, K.J.; Zambon, M.; Ellis, J.; Lewis, P.A.; Hiscox, J.A. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein. Genome Med. 2020, 12, 68. [Google Scholar] [CrossRef]
  28. Kibenge, F.S.B. Continuous surveillance and viral discovery in animals and humans are a core component of a one-health approach to address recent viral reverse zoonoses. J. Am. Vet. Med. Assoc. 2023, 261, 789–797. [Google Scholar] [CrossRef]
  29. Leifels, M.; Khalilur Rahman, O.; Sam, I.C.; Cheng, D.; Chua, F.J.D.; Nainani, D.; Kim, S.Y.; Ng, W.J.; Kwok, W.C.; Sirikanchana, K.; et al. The one health perspective to improve environmental surveillance of zoonotic viruses: Lessons from COVID-19 and outlook beyond. ISME Commun. 2022, 2, 107. [Google Scholar] [CrossRef] [PubMed]
  30. Plowright, R.K.; Ahmed, A.N.; Coulson, T.; Crowther, T.W.; Ejotre, I.; Faust, C.L.; Frick, W.F.; Hudson, P.J.; Kingston, T.; Nameer, P.O.; et al. Ecological countermeasures to prevent pathogen spillover and subsequent pandemics. Nat. Commun. 2024, 15, 2577. [Google Scholar] [CrossRef] [PubMed]
  31. Pauciullo, S.; Zulian, V.; La Frazia, S.; Paci, P.; Garbuglia, A.R. Spillover: Mechanisms, Genetic Barriers, and the Role of Reservoirs inEmerging Pathogens. Microorganisms 2024, 12, 2191. [Google Scholar] [CrossRef]
  32. Zhang, L.; Rohr, J.; Cui, R.; Xin, Y.; Han, L.; Yang, X.; Gu, S.; Du, Y.; Liang, J.; Wang, X.; et al. Biological invasions facilitate zoonotic disease emergences. Nat. Commun. 2022, 13, 1762. [Google Scholar] [CrossRef]
  33. Mahon, M.B.; Sack, A.; Aleuy, O.A.; Barbera, C.; Brown, E.; Buelow, H.; Civitello, D.J.; Cohen, J.M.; de Wit, L.A.; Forstchen, M.; et al. A meta-analysis on global change drivers and the risk of infectious disease. Nature 2024, 629, 830–836. [Google Scholar] [CrossRef]
  34. Rupasinghe, R.; Chomel, B.B.; Martínez-López, B. Climate change and zoonoses: A review of the current status, knowledge gaps, and future trends. Acta Trop. 2022, 226, 106225. [Google Scholar] [CrossRef]
  35. Reed, K.D. Viral Zoonoses. In Reference Module in Biomedical Sciences; Elsevier: Amsterdam, The Netherlands, 2018. [Google Scholar] [CrossRef]
  36. Plowright, R.K.; Parrish, C.R.; McCallum, H.; Hudson, P.J.; Ko, A.I.; Graham, A.L.; Lloyd-Smith, J.O. Pathways to Zoonotic Spillover. Nat. Rev. Microbiol. 2017, 15, 502–510. [Google Scholar] [CrossRef]
  37. Hill, S.C.; François, S.; Thézé, J.; Smith, A.L.; Simmonds, P.; Perrins, C.M.; van der Hoek, L.; Pybus, O.G. Impact of host age on viral and bacterial communities in a waterbird population. ISME J. 2023, 17, 215–226. [Google Scholar] [CrossRef]
  38. Plowright, R.K.; Eby, P.; Hudson, P.J.; Smith, I.L.; Westcott, D.; Bryden, W.L.; Middleton, D.; Reid, P.A.; McFarlane, R.A.; Martin, G.; et al. Ecological dynamics of emerging bat virus spillover. Proc. Biol. Sci. 2015, 282, 20142124. [Google Scholar] [CrossRef] [PubMed]
  39. Plowright, R.K.; Hudson, P.J. From Protein to Pandemic: The Transdisciplinary Approach Needed to Prevent Spillover and the Next Pandemic. Viruses 2021, 13, 1298. [Google Scholar] [CrossRef] [PubMed]
  40. Sánchez, C.A.; Li, H.; Phelps, K.L.; Zambrana-Torrelio, C.; Wang, L.-F.; Zhou, P.; Shi, Z.-L.; Olival, K.J.; Daszak, P. A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia. Nat. Commun. 2022, 13, 4380. [Google Scholar] [CrossRef] [PubMed]
  41. Plowright, R.K.; Peel, A.J.; Streicker, D.G.; Gilbert, A.T.; McCallum, H.; Wood, J.; Baker, M.L.; Restif, O. Transmission or Within-Host Dynamics Driving Pulses of Zoonotic Viruses in Reservoir-Host Populations. PLoS Negl. Trop. Dis. 2016, 10, e0004796. [Google Scholar] [CrossRef]
  42. Parrish, C.R.; Holmes, E.C.; Morens, D.M.; Park, E.C.; Burke, D.S.; Calisher, C.H.; Laughlin, C.A.; Saif, L.J.; Daszak, P. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol. Mol. Biol. Rev. 2008, 72, 457–470. [Google Scholar] [CrossRef]
  43. Kayode, A.J.; Banji-Onisile, F.O.; Olaniran, A.O.; Okoh, A.I. An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks. Pathogens 2021, 10, 1108. [Google Scholar] [CrossRef] [PubMed]
  44. Priya, A. Case Study Methodology of Qualitative Research: Key Attributes and Navigating the Conundrums in Its Application. Sociol. Bull. 2020, 70, 94–110. [Google Scholar] [CrossRef]
  45. Ellwanger, J.H.; Veiga, A.B.G.; Kaminski, V.L.; Valverde-Villegas, J.M.; Freitas, A.W.Q.; Chies, J.A.B. Control and prevention of infectious diseases from a One Health perspective. Genet. Mol. Biol. 2021, 44, e20200256. [Google Scholar] [CrossRef]
  46. Vora, N.M.; Hannah, L.; Walzer, C.; Vale, M.M.; Lieberman, S.; Emerson, A.; Jennings, J.; Alders, R.; Bonds, M.H.; Evans, J. Interventions to reduce risk for pathogen spillover and early disease spread to prevent outbreaks, epidemics, and pandemics. Emerg. Infect. Dis. 2023, 29, e221079. [Google Scholar] [CrossRef]
  47. Sokolow, S.H.; Nova, N.; Pepin, K.M.; Peel, A.J.; Pulliam, J.R.C.; Manlove, K.; Cross, P.C.; Becker, D.J.; Plowright, R.K.; McCallum, H.; et al. Ecological Interventions to Prevent and Manage Zoonotic Pathogen Spillover. Philos. Trans. R Soc. Lond. B Biol. Sci. 2019, 374, 20180342. [Google Scholar] [CrossRef]
  48. Leung, N.H.L. Transmissibility and transmission of respiratory viruses. Nat. Rev. Microbiol. 2021, 19, 528–545. [Google Scholar] [CrossRef]
  49. Albery, G.F.; Becker, D.J.; Brierley, L.; Brook, C.E.; Christofferson, R.C.; Cohen, L.E.; Dallas, T.A.; Eskew, E.A.; Fagre, A.; Farrell, M.J.; et al. The science of the host–virus network. Nat. Microbiol. 2021, 6, 1483–1492. [Google Scholar] [CrossRef]
  50. LaTourrette, K.; Garcia-Ruiz, H. Determinants of Virus Variation, Evolution, and Host Adaptation. Pathogens 2022, 11, 1039. [Google Scholar] [CrossRef] [PubMed]
  51. Wang, C.C.; Prather, K.A.; Sznitman, J.; Jimenez, J.L.; Lakdawala, S.S.; Tufekci, Z.; Marr, L.C. Airborne transmission of respiratory viruses. Science 2021, 373, eabd9149. [Google Scholar] [CrossRef] [PubMed]
  52. Krakoff, E.; Gagne, R.B.; VandeWoude, S.; Carver, S. Variation in Intra-individual Lentiviral Evolution Rates: A Systematic Review of Human, Nonhuman Primate, and Felid Species. J. Virol. 2019, 93, e00538-19. [Google Scholar] [CrossRef]
  53. Borremans, B.; Falvo, C.A.; Crowley, D.E.; Hoegh, A.; Lloyd-Smith, J.O.; Peel, A.J.; Restif, O.; Ruiz-Aravena, M.; Plowright, R.K. Reconstructing prevalence dynamics of wildlife pathogens from pooled and individual samples. Peer Community J. 2024, 4, e80. [Google Scholar] [CrossRef]
  54. Nomaguchi, M.; Fujita, M.; Miyazaki, Y.; Adachi, A. Viral tropism. Front. Microbiol. 2012, 3, 281. [Google Scholar] [CrossRef] [PubMed]
  55. Rothenburg, S.; Brennan, G. Species-Specific Host-Virus Interactions: Implications for Viral Host Range and Virulence. Trends Microbiol. 2020, 28, 46–56. [Google Scholar] [CrossRef]
  56. Sikkema, R.S.; Koopmans, M.P.G. Preparing for Emerging Zoonotic Viruses. In Encyclopedia of Virology; Academic Press: Cambridge, MA, USA, 2021; pp. 256–266. [Google Scholar] [CrossRef]
  57. Bean, A.G.; Baker, M.L.; Stewart, C.R.; Cowled, C.; Deffrasnes, C.; Wang, L.F.; Lowenthal, J.W. Studying immunity to zoonotic diseases in the natural host—keeping it real. Nat. Rev. Immunol. 2013, 13, 851–861. [Google Scholar] [CrossRef]
  58. Louten, J. Virus Replication. In Essential Human Virology; Academic Press: Cambridge, MA, USA, 2016; pp. 49–70. [Google Scholar] [CrossRef]
  59. Badu, K.; Oyebola, K.; Zahouli, J.Z.B.; Fagbamigbe, A.F.; de Souza, D.K.; Dukhi, N.; Amankwaa, E.F.; Tolba, M.F.; Sylverken, A.A.; Mosi, L.; et al. SARS-CoV-2 Viral Shedding and Transmission Dynamics: Implications of WHO COVID-19 Discharge Guidelines. Front. Med. 2021, 8, 648660. [Google Scholar] [CrossRef]
  60. Lozach, P.Y. Cell Biology of Viral Infections. Cells 2020, 9, 2431. [Google Scholar] [CrossRef]
  61. Liu, W.-D.; Chang, S.-Y.; Wang, J.-T.; Tsai, M.-J.; Hung, C.-C.; Hsu, C.-L.; Chang, S.-C. Prolonged virus shedding even after seroconversion in a patient with COVID-19. J. Infect. 2020, 81, 318–356. [Google Scholar] [CrossRef]
  62. Herbert, J.A.; Panagiotou, S. Immune Response to Viruses. In Encyclopedia of Infection and Immunity; Elsevier: Amsterdam, The Netherlands, 2022; pp. 429–444. [Google Scholar] [CrossRef]
  63. Li, D.; Wu, M. Pattern recognition receptors in health and diseases. Signal Transduct. Target. Ther. 2021, 6, 291. [Google Scholar] [CrossRef] [PubMed]
  64. Catania, L.J. The adaptive (aka “acquired”) immune system: From friend to foe. In The Paradox of the Immune System; Academic Press: Cambridge, MA, USA, 2022; pp. 25–43. [Google Scholar] [CrossRef]
  65. Chi, H.; Pepper, M.; Thomas, P.G. Principles and therapeutic applications of adaptive immunity. Cell 2024, 187, 2052–2078. [Google Scholar] [CrossRef] [PubMed]
  66. Djordjevic, S.P.; Jarocki, V.M.; Seemann, T.; Cummins, M.L.; Watt, A.E.; Drigo, B.; Wyrsch, E.R.; Reid, C.J.; Donner, E.; Howden, B.P. Genomic surveillance for antimicrobial resistance—A One Health perspective. Nat. Rev. Genet. 2024, 25, 142–157. [Google Scholar] [CrossRef]
  67. Baker, K.S.; Jauneikaite, E.; Hopkins, K.L.; Lo, S.W.; Sánchez-Busó, L.; Getino, M.; Howden, B.P.; Holt, K.E.; Musila, L.A.; Hendriksen, R.S.; et al. Genomics for public health and international surveillance of antimicrobial resistance. Lancet Microbe 2023, 4, e1047–e1055. [Google Scholar] [CrossRef]
  68. Liu, W.J.; Xu, J. The Arms Race in the War Between Virus and Host: Implications for Anti-Infection Immunity. Infect. Dis. Immun. 2022, 2, 129–131. [Google Scholar] [CrossRef]
  69. Takano, T.; Morikawa, M.; Adachi, Y.; Kabasawa, K.; Sax, N.; Moriyama, S.; Sun, L.; Isogawa, M.; Nishiyama, A.; Onodera, T.; et al. Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine. Cell Rep. Med. 2022, 3, 100631. [Google Scholar] [CrossRef]
  70. Hsu, A.P.; Holland, S.M. Host genetics of innate immune system in infection. Curr. Opin. Immunol. 2022, 74, 140–149. [Google Scholar] [CrossRef]
  71. Biesecker, L.G.; Spinner, N.B. A genomic view of mosaicism and human disease. Nat. Rev. Genet. 2013, 14, 307–320. [Google Scholar] [CrossRef] [PubMed]
  72. Strumillo, S.T.; Kartavykh, D.; de Carvalho, F.F., Jr.; Cruz, N.C.; de Souza Teodoro, A.C.; Sobhie Diaz, R.; Curcio, M.F. Host-virus interaction and viral evasion. Cell Biol. Int. 2021, 45, 1124–1147. [Google Scholar] [CrossRef] [PubMed]
  73. Naz, S.S.; Aslam, A.; Malik, T. An Overview of Immune Evasion Strategies of DNA and RNA Viruses. Infect. Disord. Drug Targets 2021, 21, e300821192322. [Google Scholar] [CrossRef]
  74. Wang, S.; Liang, B.; Wang, W.; Li, L.; Feng, N.; Zhao, Y.; Wang, T.; Yan, F.; Yang, S.; Xia, X. Viral vectored vaccines: Design, development, preventive and therapeutic applications in human diseases. Signal Transduct. Target. Ther. 2023, 8, 149. [Google Scholar] [CrossRef]
  75. Mosa, A.I. Antigenic Variability. Front. Immunol. 2020, 11, 2057. [Google Scholar] [CrossRef] [PubMed]
  76. Genereux, D.P.; Serres, A.; Armstrong, J.; Johnson, J.; Marinescu, V.D.; Murén, E.; Juan, D.; Bejerano, G.; Casewell, N.R.; Chemnick, L.G.; et al. A comparative genomics multitool for scientific discovery and conservation. Nature 2020, 587, 240–245. [Google Scholar] [CrossRef] [PubMed]
  77. Alföldi, J.; Lindblad-Toh, K. Comparative genomics as a tool to understand evolution and disease. Genome Res. 2013, 23, 1063–1068. [Google Scholar] [CrossRef]
  78. Yamaoka, S.; Ebihara, H. Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity. Virulence 2021, 12, 885–901. [Google Scholar] [CrossRef]
  79. Xu, C.; Wang, Z.; Yu, B.; Pan, Z.; Ni, J.; Feng, Y.; Huang, S.; Wu, M.; Zhou, J.; Fang, L.; et al. Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay. Virus Res. 2024, 346, 199410. [Google Scholar] [CrossRef]
  80. Jones, J.E.; Le Sage, V.; Lakdawala, S.S. Viral and host heterogeneity and their effects on the viral life cycle. Nat. Rev. Microbiol. 2021, 19, 272–282. [Google Scholar] [CrossRef] [PubMed]
  81. Kachuri, L.; Francis, S.S.; Morrison, M.L.; Wendt, G.A.; Bossé, Y.; Cavazos, T.B.; Rashkin, S.R.; Ziv, E.; Witte, J.S. The landscape of host genetic factors involved in immune response to common viral infections. Genome Med. 2020, 12, 93. [Google Scholar] [CrossRef]
  82. Kwok, A.J.; Mentzer, A.; Knight, J.C. Host genetics and infectious disease: New tools, insights and translational opportunities. Nat. Rev. Genet. 2021, 22, 137–153. [Google Scholar] [CrossRef]
  83. Pérez-Losada, M.; Arenas, M.; Galán, J.C.; Palero, F.; González-Candelas, F. Recombination in viruses: Mechanisms, methods of study, and evolutionary consequences. Infect. Genet. Evol. 2015, 30, 296–307. [Google Scholar] [CrossRef]
  84. Vadapalli, S.; Abdelhalim, H.; Zeeshan, S.; Ahmed, Z. Artificial intelligence and machine learning approaches using gene expression and variant data for personalized medicine. Brief. Bioinform. 2022, 23, bbac191. [Google Scholar] [CrossRef] [PubMed]
  85. Yajima, H.; Anraku, Y.; Kaku, Y.; Kimura, K.T.; Plianchaisuk, A.; Okumura, K.; Nakada-Nakura, Y.; Atarashi, Y.; Hemmi, T.; Kuroda, D.; et al. Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1. Nat. Commun. 2024, 15, 8574. [Google Scholar] [CrossRef] [PubMed]
  86. Xue, S.; Han, Y.; Wu, F.; Wang, Q. Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion. Protein Cell 2024, 15, 403–418. [Google Scholar] [CrossRef]
  87. Markin, A.; Macken, C.A.; Baker, A.L.; Anderson, T.K. Revealing Reassortment in Influenza A Viruses with TreeSort. Mol. Biol. Evol. 2025, 42, msaf133. [Google Scholar] [CrossRef]
  88. Fermin, G. Host Range, Host–Virus Interactions, and Virus Transmission. In Viruses; Academic Press: Cambridge, MA, USA, 2018; pp. 101–134. [Google Scholar] [CrossRef]
  89. Aljabali, A.A.A.; Lundstrom, K.; Hromić-Jahjefendić, A.; El-Baky, N.A.; Nawn, D.; Hassan, S.S.; Rubio-Casillas, A.; Redwan, E.M.; Uversky, V.N. The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications. Viruses 2025, 17, 985. [Google Scholar] [CrossRef]
  90. Longdon, B.; Brockhurst, M.A.; Russell, C.A.; Welch, J.J.; Jiggins, F.M. The evolution and genetics of virus host shifts. PLoS Pathog. 2014, 10, e1004395. [Google Scholar] [CrossRef]
  91. Szpara, M.L.; Van Doorslaer, K. Mechanisms of DNA Virus Evolution. In Encyclopedia of Virology; Academic Press: Cambridge, MA, USA, 2021; pp. 71–78. [Google Scholar] [CrossRef]
  92. Rampersad, S.; Tennant, P. Replication and Expression Strategies of Viruses. In Viruses; Academic Press: Cambridge, MA, USA, 2018; pp. 55–82. [Google Scholar] [CrossRef]
  93. Dillner, J. Early detection and prevention. Mol. Oncol. 2019, 13, 591–598. [Google Scholar] [CrossRef]
  94. Ameni, G.; Zewude, A.; Tulu, B.; Derara, M.; Bayissa, B.; Mohammed, T.; Degefa, B.A.; Hamad, M.E.; Tibbo, M.; Barigye, R. A Narrative Review on the Pandemic Zoonotic RNA Virus Infections Occurred During the Last 25 Years. J. Epidemiol. Glob. Health 2024, 14, 1397–1412. [Google Scholar] [CrossRef] [PubMed]
  95. Sardanyés, J.; Perales, C.; Domingo, E.; Elena, S.F. Quasispecies theory and emerging viruses: Challenges and applications. npj Viruses 2024, 2, 54. [Google Scholar] [CrossRef] [PubMed]
  96. Kapli, P.; Yang, Z.; Telford, M.J. Phylogenetic tree building in the genomic age. Nat. Rev. Genet. 2020, 21, 428–444. [Google Scholar] [CrossRef] [PubMed]
  97. Sharan, M.; Vijay, D.; Yadav, J.P.; Bedi, J.S.; Dhaka, P. Surveillance and response strategies for zoonotic diseases: A comprehensive review. Sci. One Health 2023, 2, 100050. [Google Scholar] [CrossRef]
  98. Singh, B.B.; Ward, M.P.; Dhand, N.K. Host characteristics and their influence on zoonosis, disease emergence and multi-host pathogenicity. One Health 2023, 17, 100596. [Google Scholar] [CrossRef]
  99. Seal, S.; Dharmarajan, G.; Khan, I. Evolution of pathogen tolerance and emerging infections: A missing experimental paradigm. ELife. 2021, 10, e68874. [Google Scholar] [CrossRef]
  100. Santangelo, J.S.; Johnson, M.T.J.; Ness, R.W. Modern spandrels: The roles of genetic drift, gene flow and natural selection in the evolution of parallel clines. Proc. Biol. Sci. 2018, 285, 20180230. [Google Scholar] [CrossRef] [PubMed]
  101. Karras, P.; Black, J.R.M.; McGranahan, N.; Marine, J.-C. Decoding the interplay between genetic and non-genetic drivers of metastasis. Nature 2024, 629, 543–554. [Google Scholar] [CrossRef] [PubMed]
  102. Aljabali, A.A.A.; Obeid, M.; Gammoh, O.; El-Tanani, M.; Tambuwala, M.M. Guardians at the gate: Unraveling Type I interferon’s role and challenges posed by anti-interferon antibodies in COVID-19. Prog. Mol. Biol. Transl. Sci. 2025, 213, 135–169. [Google Scholar] [PubMed]
  103. Yi, B.; Deng, Q.; Guo, C.; Li, X.; Wu, Q.; Zha, R.; Wang, X.; Lu, J. Evaluating the zoonotic potential of RNA viromes of rodents provides new insight into rodent-borne zoonotic pathogens in Guangdong, China. One Health 2023, 17, 100631. [Google Scholar] [CrossRef]
  104. Meckawy, R.; Stuckler, D.; Mehta, A.; Al-Ahdal, T.; Doebbeling, B.N. Effectiveness of early warning systems in the detection of infectious diseases outbreaks: A systematic review. BMC Public Health 2022, 22, 2216. [Google Scholar] [CrossRef]
  105. Hausdorff, W.P.; Madhi, S.A.; Kang, G.; Kaboré, L.; Bayona, M.T.; Giersing, B.K. Facilitating the development of urgently required combination vaccines. Lancet Glob. Health 2024, 2, e1059–e1067. [Google Scholar] [CrossRef]
  106. Ghai, R.R.; Wallace, R.M.; Kile, J.C.; Shoemaker, T.R.; Vieira, A.R.; Negron, M.E.; Shadomy, S.V.; Sinclair, J.R.; Goryoka, G.W.; Salyer, S.J.; et al. A generalizable one health framework for the control of zoonotic diseases. Sci. Rep. 2022, 12, 8588. [Google Scholar] [CrossRef]
  107. Hong, R.; Walker, R.; Hovan, G.; Henry, L.; Pescatore, R. The Power of Public Health Surveillance. Dela J. Public Health 2020, 6, 60–63. [Google Scholar] [CrossRef]
  108. Satam, H.; Joshi, K.; Mangrolia, U.; Waghoo, S.; Zaidi, G.; Rawool, S.; Thakare, R.P.; Banday, S.; Mishra, A.K.; Das, G.; et al. Next-Generation Sequencing Technology: Current Trends and Advancements. Biology 2023, 12, 997. [Google Scholar] [CrossRef]
  109. Cassedy, A.; Parle-McDermott, A.; O’Kennedy, R. Virus Detection: A Review of the Current and Emerging Molecular and Immunological Methods. Front. Mol. Biosci. 2021, 8, 637559. [Google Scholar] [CrossRef] [PubMed]
  110. Rahman, M.T.; Sobur, M.A.; Islam, M.S.; Ievy, S.; Hossain, M.J.; El Zowalaty, M.E.; Rahman, A.T.; Ashour, H.M. Zoonotic Diseases: Etiology, Impact, and Control. Microorganisms 2020, 8, 1405. [Google Scholar] [CrossRef]
  111. Ranapurwala, S.I.; Cavanaugh, J.E.; Young, T.; Wu, H.; Peek-Asa, C.; Ramirez, M.R. Public health application of predictive modeling: An example from farm vehicle crashes. Inj. Epidemiol. 2019, 6, 31. [Google Scholar] [CrossRef]
  112. Mohamed, N. Current trends in AI and ML for cybersecurity: A state-of-the-art survey. Cogent Eng. 2023, 10, 2272358. [Google Scholar] [CrossRef]
  113. Mackenzie, J.S.; Jeggo, M. The One Health Approach-Why Is It So Important? Trop. Med. Infect. Dis. 2019, 4, 88. [Google Scholar] [CrossRef]
  114. Ndishimye, P.; Umuhoza, T.; Umutoni, B.; Zakham, F.; Ndayambaje, M.; Hewins, B.; Ngabo Gasana, M.; Ostadgavahi, A.T.; Sganzerla, G.; Ndayisenga, F.; et al. Rift Valley Fever outbreaks in the East African Community: Insights from ProMed data (2010–2024). Front. Public Health 2024, 12, 1298594. [Google Scholar] [CrossRef]
  115. Rostal, M.K.; Thompson, P.N.; Anyamba, A.; Bett, B.; Cêtre-Sossah, C.; Chevalier, V.; Guarido, M.; Karesh, W.B.; Kemp, A.; LaBeaud, A.D.; et al. Rift Valley fever epidemiology: Shifting the paradigm and rethinking research priorities. Lancet Planet. Health 2025, 9, 101299. [Google Scholar] [CrossRef]
  116. Mackenzie, J.S.; McKinnon, M.; Jeggo, M. One Health: From Concept to Practice. In Confronting Emerging Zoonoses; Springer: Berlin/Heidelberg, Germany, 2014; pp. 163–189. [Google Scholar] [CrossRef]
  117. Pepin, K.M.; Carlisle, K.; Anderson, D.; Baker, M.G.; Chipman, R.B.; Benschop, J.; French, N.P.; Greenhalgh, S.; McDougall, S.; Muellner, P.; et al. Steps towards operationalizing One Health approaches. One Health 2024, 18, 100740. [Google Scholar] [CrossRef]
  118. Aggarwal, D.; Ramachandran, A. One Health Approach to Address Zoonotic Diseases. Indian. J. Community Med. 2020, 45, S6–S8. [Google Scholar] [CrossRef] [PubMed]
  119. Alahmari, A.A.; Almuzaini, Y.; Alamri, F.; Alenzi, R.; Khan, A.A. Strengthening global health security through health early warning systems: A literature review and case study. J. Infect. Public Health 2024, 17, 85–95. [Google Scholar] [CrossRef] [PubMed]
  120. Machalaba, C.; Raufman, J.; Anyamba, A.; Berrian, A.M.; Berthe, F.C.J.; Gray, G.C.; Jonas, O.; Karesh, W.B.; Larsen, M.H.; Laxminarayan, R.; et al. Applying a One Health Approach in Global Health and Medicine: Enhancing Involvement of Medical Schools and Global Health Centers. Ann. Glob. Health 2021, 87, 30. [Google Scholar] [CrossRef] [PubMed]
  121. Almeida-Pinto, F.; Pinto, R.; Rocha, J. Navigating the Complex Landscape of Ebola Infection Treatment: A Re-view of Emerging Pharmacological Approaches. Infect. Dis. Ther. 2024, 13, 21–55. [Google Scholar] [CrossRef]
  122. Jacob, S.T.; Crozier, I.; Fischer, W.A., 2nd; Hewlett, A.; Kraft, C.S.; de La Vega, M.-A.; Soka, M.J.; Wahl, V.; Griffiths, A.; Bollinger, L.; et al. Ebola virus disease. Nat. Rev. Dis. Primers 2020, 6, 13. [Google Scholar] [CrossRef] [PubMed]
  123. Blagodatski, A.; Trutneva, K.; Glazova, O.; Mityaeva, O.; Shevkova, L.; Kegeles, E.; Onyanov, N.; Fede, K.; Maznina, A.; Khavina, E.; et al. Avian Influenza in Wild Birds and Poultry: Dissemination Pathways, Monitoring Methods, and Virus Ecology. Pathogens 2021, 10, 630. [Google Scholar] [CrossRef]
  124. Simancas-Racines, A.; Cadena-Ullauri, S.; Guevara-Ramírez, P.; Zambrano, A.K.; Simancas-Racines, D. Avian Influenza: Strategies to Manage an Outbreak. Pathogens 2023, 12, 610. [Google Scholar] [CrossRef]
  125. Li, J.; Lai, S.; Gao, G.F.; Shi, W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature 2021, 600, 408–418. [Google Scholar] [CrossRef]
  126. Hiscott, J.; Alexandridi, M.; Muscolini, M.; Tassone, E.; Palermo, E.; Soultsioti, M.; Zevini, A. The global impact of the coronavreirus pandemic. Cytokine Growth Factor Rev. 2020, 53, 1–9. [Google Scholar] [CrossRef] [PubMed]
  127. Oude Munnink, B.B.; Worp, N.; Nieuwenhuijse, D.F.; Sikkema, R.S.; Haagmans, B.; Fouchier, R.A.M.; Koopmans, M. The next phase of SARS-CoV-2 surveillance: Real-time molecular epidemiology. Nat. Med. 2021, 27, 1518–1524. [Google Scholar] [CrossRef]
  128. Al-Qaaneh, A.M.; Alshammari, T.; Aldahhan, R.; Aldossary, H.; Alkhalifah, Z.A.; Borgio, J.F. Genome composition and genetic characterization of SARS-CoV-2. Saudi J. Biol. Sci. 2021, 28, 1978–1989. [Google Scholar] [CrossRef]
  129. Aljabali, A.A.A.; Obeid, M.A.; Tambuwala, M.M. Fast track vaccine development for COVID-19 and impact of emerging variants. In SARS-CoV-2 Variants and Global Population Vulnerability; Apple Academic Press: Burlington, ON, Canada, 2024; pp. 225–247. [Google Scholar]
  130. Buseh, A.G.; Stevens, P.E.; Bromberg, M.; Kelber, S.T. The Ebola epidemic in West Africa: Challenges, opportunities, and policy priority areas. Nurs. Outlook 2015, 63, 30–40. [Google Scholar] [CrossRef]
  131. Heymann, D.L.; Chen, L.; Takemi, K.; Fidler, D.P.; Tappero, J.W.; Thomas, M.J.; Kenyon, T.A.; Frieden, T.R.; Yach, D.; Nishtar, S.; et al. Global health security: The wider lessons from the west African Ebola virus disease epidemic. Lancet 2015, 385, 1884–1901. [Google Scholar] [CrossRef]
  132. Saldaña, F.; Stollenwerk, N.; Van Dierdonck, J.B.; Aguiar, M. Modeling spillover dynamics: Understanding emerging pathogens of public health concern. Sci. Rep. 2024, 14, 9823. [Google Scholar] [CrossRef] [PubMed]
  133. Ellwanger, J.H.; Chies, J.A.B. Zoonotic spillover: Understanding basic aspects for better prevention. Genet. Mol. Biol. 2021, 44, e20200355. [Google Scholar] [CrossRef]
  134. Khorram-Manesh, A.; Dulebenets, M.A.; Goniewicz, K. Implementing Public Health Strategies-The Need for Educational Initiatives: A Systematic Review. Int. J. Environ. Res. Public Health 2021, 18, 5888. [Google Scholar] [CrossRef]
  135. Pollard, A.J.; Bijker, E.M. A guide to vaccinology: From basic principles to new developments. Nat. Rev. Immunol. 2021, 21, 83–100. [Google Scholar] [CrossRef]
  136. Alagheband Bahrami, A.; Azargoonjahromi, A.; Sadraei, S.; Aarabi, A.; Payandeh, Z.; Rajabibazl, M. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19). Cell Mol. Biol. Lett. 2022, 27, 38. [Google Scholar] [CrossRef]
  137. Aljabali, A.A.A.; Obeid, M.A.; El-Tanani, M.; Mishra, V.; Mishra, Y.; Tambuwala, M.M. Precision epidemiology at the nexus of mathematics and nanotechnology: Unraveling the dance of viral dynamics. Gene 2024, 905, 148174. [Google Scholar] [CrossRef] [PubMed]
  138. Carpenter, A.; Waltenburg, M.A.; Hall, A.; Kile, J.; Killerby, M.; Knust, B.; Negron, M.; Nichols, M.; Wallace, R.M.; Behravesh, C.B.; et al. Vaccine Preventable Zoonotic Diseases: Challenges and Opportunities for Public Health Progress. Vaccines 2022, 10, 993. [Google Scholar] [CrossRef]
  139. Aljabali, A.A.A.; Bashatwah, R.M.; Obeid, M.A.; Mishra, V.; Mishra, Y.; Serrano-Aroca, Á.; Lundstrom, K.; Tambuwala, M.M. Current state of, prospects for, and obstacles to mRNA vaccine development. Drug Discov. Today 2023, 28, 103458. [Google Scholar] [CrossRef]
  140. Mahajan, S.; Choudhary, S.; Kumar, P.; Tomar, S. Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens. Bioorg Med. Chem. 2021, 46, 116356. [Google Scholar] [CrossRef]
  141. Pardi, N.; Weissman, D. Development of vaccines and antivirals for combating viral pandemics. Nat. Biomed. Eng. 2020, 4, 1128–1133. [Google Scholar] [CrossRef]
  142. Meganck, R.M.; Baric, R.S. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases. Nat. Med. 2021, 27, 401–410. [Google Scholar] [CrossRef]
  143. Kaur, J.; Butt, Z.A. AI-driven epidemic intelligence: The future of outbreak detection and response. Front. Artif. Intell. 2025, 8, 1645467. [Google Scholar] [CrossRef]
  144. Patel, A.; Patel, S.; Fulzele, P.; Mohod, S.; Chhabra, K.G. Quarantine an effective mode for control of the spread of COVID-19? A review. J. Family Med. Prim. Care 2020, 9, 3867–3871. [Google Scholar] [CrossRef]
  145. Wu, S.; Neill, R.; De Foo, C.; Chua, A.Q.; Jung, A.S.; Haldane, V.; Abdalla, S.M.; Guan, W.J.; Singh, S.; Nordström, A.; et al. Aggressive containment, suppression, and mitigation of covid-19: Lessons learnt from eight countries. BMJ 2021, 375, e067508. [Google Scholar] [CrossRef]
  146. Gros, C.; Valenti, R.; Schneider, L.; Valenti, K.; Gros, D. Containment efficiency and control strategies for the corona pandemic costs. Sci. Rep. 2021, 11, 6848. [Google Scholar] [CrossRef]
  147. Haldane, V.; Jung, A.-S.; De Foo, C.; Bonk, M.; Jamieson, M.; Wu, S.; Verma, M.; Abdalla, S.M.; Singh, S.; Nordström, A. Strengthening the basics: Public health responses to prevent the next pandemic. BMJ 2021, 375, e067510. [Google Scholar] [CrossRef]
  148. Kaner, J.; Schaack, S. Understanding Ebola: The 2014 epidemic. Global Health 2016, 12, 53. [Google Scholar] [CrossRef]
  149. Nopita Wati, N.M.; Juanamasta, I.G.; Thongsalab, J.; Yunibhand, J. Strategies and challenges in addressing ethical issues in the hospital context: A phenomenological study of nurse team leaders. Belitung Nurs. J. 2023, 9, 139–144. [Google Scholar] [CrossRef]
  150. Esposito, M.M.; Turku, S.; Lehrfield, L.; Shoman, A. The Impact of Human Activities on Zoonotic Infection Transmissions. Animals 2023, 13, 1646. [Google Scholar] [CrossRef]
  151. Friant, S.; Bonwitt, J.; Ayambem, W.A.; Ifebueme, N.M.; Alobi, A.O.; Otukpa, O.M.; Bennett, A.J.; Shea, C.; Rothman, J.M.; Goldberg, T.L.; et al. Zootherapy as a potential pathway for zoonotic spillover: A mixed-methods study of the use of animal products in medicinal and cultural practices in Nigeria. One Health Outlook 2022, 4, 5. [Google Scholar] [CrossRef]
  152. Salyer, S.J.; Silver, R.; Simone, K.; Behravesh, C.B. Prioritizing zoonoses for global health capacity building—Themes from One Health zoonotic disease workshops in 7 countries, 2014–2016. Emerg. Infect. Dis. 2017, 23, S55. [Google Scholar] [CrossRef]
  153. Kheirallah, K.A.; Al-Mistarehi, A.-H.; Alsawalha, L.; Hijazeen, Z.; Mahrous, H.; Sheikali, S.; Al-Ramini, S.; Maayeh, M.; Dodeen, R.; Farajeh, M. Prioritizing zoonotic diseases utilizing the One Health approach: Jordan’s experience. One Health 2021, 13, 100262. [Google Scholar] [CrossRef]
  154. Goryoka, G.W.; Lokossou, V.K.; Varela, K.; Oussayef, N.; Kofi, B.; Iwar, V.; Behravesh, C.B. Prioritizing Zoonotic diseases using a Multisectoral, one health approach for the economic community of West African States (ECOWAS). One Health Outlook 2021, 3, 24. [Google Scholar] [CrossRef]
  155. Medley, A.M.; Gasanani, J.; Nyolimati, C.A.; McIntyre, E.; Ward, S.; Okuyo, B.; Kabiito, D.; Bender, C.; Jafari, Z.; LaMorde, M. Preventing the cross—Border spread of zoonotic diseases: Multisectoral community engagement to characterize animal mobility—Uganda, 2020. Zoonoses Public Health 2021, 68, 747–759. [Google Scholar] [CrossRef]
  156. Cunningham, N.; Hopkins, S. Lessons identified for a future pandemic. J. Antimicrob. Chemother. 2023, 78, ii43–ii49. [Google Scholar] [CrossRef]
  157. Reddy, B.V.; Gupta, A. Importance of effective communication during COVID-19 infodemic. J. Family Med. Prim. Care 2020, 9, 3793–3796. [Google Scholar] [CrossRef]
  158. Griffiths, A.-J.; Alsip, J.; Hart, S.R.; Round, R.L.; Brady, J. Together We Can Do So Much: A Systematic Review and Conceptual Framework of Collaboration in Schools. Can. J. Sch. Psychol. 2020, 36, 59–85. [Google Scholar] [CrossRef]
  159. Abrahim, A.; Bekele, B.; Tahir, M.; Ahmed, S.; Ahmedin, L. Associations of community knowledge, perceptions, and practices related to zoonotic disease with sociodemographic factors in and around Chiro Town, Eastern Ethiopia: A cross-sectional study. One Health Outlook 2024, 6, 10. [Google Scholar] [CrossRef]
  160. Serrano, I.; Gomes, D.; Ramilo, D.; Rebelo, M.T.; da Fonseca, I.P.; Moreira, A.; Oliveira, M. An overview of zoonotic disease outbreaks and its forensic management over time. J. Forensic Sci. 2019, 64, 1304–1311. [Google Scholar] [CrossRef]
  161. Shchelkunov, S.N. An increasing danger of zoonotic orthopoxvirus infections. PLoS Pathog. 2013, 9, e1003756. [Google Scholar] [CrossRef]
  162. Zumla, A.; Dar, O.; Kock, R.; Muturi, M.; Ntoumi, F.; Kaleebu, P.; Eusebio, M.; Mfinanga, S.; Bates, M.; Mwaba, P. Taking forward a ‘One Health’approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential. Int. J. Infect. Dis. 2016, 47, 5–9. [Google Scholar] [CrossRef]
  163. Kolla, R.A.; Lokugalappatti, L.G.S.; Clark, D.A.; Brook, R.K. Enhancing inter—Organizational collaboration for wildlife disease surveillance in Sri Lanka. Zoonoses Public Health 2022, 69, 792–805. [Google Scholar] [CrossRef]
  164. Yasobant, S.; Bruchhausen, W.; Saxena, D.; Falkenberg, T. ‘One Health’Actors in Multifaceted Health Systems: An Operational Case for India. Healthcare 2020, 8, 387. [Google Scholar] [CrossRef]
  165. Scotch, M.; Mattocks, K.; Rabinowitz, P.; Brandt, C. A Qualitative Study of State—Level Zoonotic Disease Surveillance in New England. Zoonoses Public Health 2011, 58, 131–139. [Google Scholar] [CrossRef]
  166. Shiferaw, M.L.; Doty, J.B.; Maghlakelidze, G.; Morgan, J.; Khmaladze, E.; Parkadze, O.; Donduashvili, M.; Wemakoy, E.O.; Muyembe, J.J.; Mulumba, L.; et al. Frameworks for Preventing, Detecting, and Controlling Zoonotic Diseases. Emerg. Infect. Dis. 2017, 23, S71–S76. [Google Scholar] [CrossRef]
Figure 1. Direct versus indirect zoonotic viral spillover. Understanding the intricate details of zoonotic spillover processes is crucial for preventing potential threats to public health, as a proactive approach is more efficient than responding to existing outbreaks.
Figure 1. Direct versus indirect zoonotic viral spillover. Understanding the intricate details of zoonotic spillover processes is crucial for preventing potential threats to public health, as a proactive approach is more efficient than responding to existing outbreaks.
Zoonoticdis 05 00035 g001
Figure 2. The adaptive immune system’s response to viral infections is long-term. After initial activation and antigen presentation, secreted antibodies can identify and clear new infections, even if a different strain of microorganisms causes them.
Figure 2. The adaptive immune system’s response to viral infections is long-term. After initial activation and antigen presentation, secreted antibodies can identify and clear new infections, even if a different strain of microorganisms causes them.
Zoonoticdis 05 00035 g002
Figure 3. The SARS-CoV-2 virus took many years to mutate from the original virus (a Bat coronavirus) into the strain that infected the intermediate host. The subsequent spillover to humans occurred more quickly, and the human-to-human transmission leading to the pandemic was so rapid that it caught the whole globe by surprise. Possible steps to prevent this pandemic included implementing effective surveillance measures to prevent human spillover. Another vital action is having a vaccine ready for administration to minimize the number of people infected by this virus.
Figure 3. The SARS-CoV-2 virus took many years to mutate from the original virus (a Bat coronavirus) into the strain that infected the intermediate host. The subsequent spillover to humans occurred more quickly, and the human-to-human transmission leading to the pandemic was so rapid that it caught the whole globe by surprise. Possible steps to prevent this pandemic included implementing effective surveillance measures to prevent human spillover. Another vital action is having a vaccine ready for administration to minimize the number of people infected by this virus.
Zoonoticdis 05 00035 g003
Table 1. Strengths, Weaknesses, Opportunities, and Threats of Understanding Spillover Events.
Table 1. Strengths, Weaknesses, Opportunities, and Threats of Understanding Spillover Events.
StrengthsWeaknesses
Preventive Measures: Understanding spillover events allows for proactive measures to prevent zoonotic outbreaks.Complexity: The topic is highly complex, spanning multiple disciplines and factors, making effective communication challenging.
Global Health Security: Knowledge of cross-species transmission is vital for pandemic preparedness and protecting human health.Ethical Dilemmas: There can be a conflict between the urge to control disease and maintaining high ethical standards in the treatment of animals and ecosystems.
One Health Approach: This complements the holistic approach to health, encompassing human, animal, and environmental well-being.Resource-Intensive: The study on spillover is comprehensive; it requires significant resources and time to sustain in the long term.
Biodiversity Conservation: By understanding these spillover events, support can be provided to population survival and to wildlife and ecosystem stability.Knowledge gaps: Despite advances, the mechanisms and risk factors underlying spillover remain poorly understood.
Scientific Insights: Research within this framework can provide crucial scientific insight into virus evolutionary pathways and their genetic determinants.Interconnectedness: The interconnected zoonotic diseases make it difficult to pinpoint causality and predict outbreaks
OpportunitiesThreats
Pandemic Prevention: The practical study of spillover events can help prevent future pandemics and, in doing so, save lives and resources.Re-emerging Diseases: The constant re-emergence of diseases poses a continuous threat to global health.
Technological innovations, such as advances in genomics, surveillance, and data analytics, provide new tools for studying and predicting pathogen spillover events.Resource Constraints: Limited funds and resources may not permit rigorous research and preparedness efforts.
Public health policies: Research in this area can thus help to actualize evidence-based public health policies and interventions.Climate change: changes in the distribution of zoonotic pathogens and their hosts can be attributed to environmental variations associated with climate change.
Community Engagement: There are many ways through which communities and indigenous knowledge can be used to prevent zoonotic diseases.Antimicrobial Resistance: Zoonotic infections can contribute to the spread of antimicrobial resistance, as dual pathogens pose a threat.
Conservation Synergy: Jointly, studies on zoonotic diseases can advance conservation measures for biodiversity and vice versa.Complacency: The feeling that, without an immediate crisis, there is often complacency regarding research, preparedness, and public health efforts.
Table 2. Advantages and Disadvantages of Studying Zoonotic Threats.
Table 2. Advantages and Disadvantages of Studying Zoonotic Threats.
AdvantagesDisadvantages
1. Early Detection and Prevention1. Ethical Dilemmas
- Identifying potential zoonotic threats before they become pandemics.- Balancing disease control with animal welfare and conservation.
- Implementing timely public health measures.- Difficult ethical decisions regarding culling or interventions.
- Reducing human suffering and healthcare costs.- Potential backlash from affected communities.
2. Global Health Security2. Resource-Intensive Research
- Enhancing global readiness for pandemics.- Need for substantial funding and resources.
- Strengthening international cooperation.- Long-term commitment to comprehensive studies.
- Minimizing the economic impact of outbreaks.- Limited availability of specialized expertise.
3. One Health Approach3. Knowledge Gaps
- Recognizing the interconnectedness of health in humans, animals, and ecosystems.- Incomplete understanding of spillover mechanisms.
- Promoting collaborative research across disciplines.- Gaps in identifying reservoir hosts and intermediate hosts.
- Enhancing surveillance in wildlife and human populations.- Lack of data on rare or undetected spillover events.
4. Scientific Insights4. Complexity of Cross-Species Transmission
- Advancing our understanding of viral evolution and adaptation.- Cross-species transmission involves intricate processes.
- Identifying genetic determinants of host switching.- Difficulties in predicting when and where spillover may occur.
- Facilitating the development of targeted interventions.- The intricate relationships among viruses, hosts, and environments are a topic of significant interest. These interactions can be quite complex and multifaceted.
5. Biodiversity Conservation5. Interdisciplinary Collaboration
- Recognizing the role of zoonotic diseases in ecosystem dynamics.- Coordination among various scientific disciplines is challenging.
- Promoting sustainable land use and wildlife conservation.- Different priorities and research methods across fields.
- Reducing the impact of diseases on vulnerable wildlife populations.- Communication barriers between scientists and policymakers.
6. Public Health Policies6. Resource Constraints
- Informing evidence-based public health policies.- Limited funding for zoonotic disease research.
- Guiding interventions and preparedness efforts.- Limited access to public health infrastructure in certain areas.
- Engaging communities in disease prevention.- The issue of unequal access to resources and expertise is a critical problem. The uneven distribution of these essential elements hinders the progress of those who lack them, creating an uneven playing field.
7. Ethical and Societal Considerations7. Constant Threat of Emerging Diseases
- Balancing human health needs with ethical treatment of animals and ecosystems.- Ongoing emergence of new zoonotic diseases.
- Fostering awareness of cultural practices affecting zoonotic risk.- Persistent need for vigilance and preparedness.
- Learning from past outbreaks to shape future policies.- Potential for novel threats with unknown consequences.
Table 3. Host Range of Selected Zoonotic Viruses. This table provides a comparative summary of the primary reservoir hosts, intermediate hosts, and human outcomes associated with major zoonotic viruses, illustrating how host range diversity contributes to spillover risk and public health burden.
Table 3. Host Range of Selected Zoonotic Viruses. This table provides a comparative summary of the primary reservoir hosts, intermediate hosts, and human outcomes associated with major zoonotic viruses, illustrating how host range diversity contributes to spillover risk and public health burden.
VirusPrimary Reservoir HostIntermediate Host(s)Human Outcome
Ebola virusFruit bats (Pteropodidae)Non-human primates, duikersSevere hemorrhagic fever, high case fatality
Avian Influenza (H5N1, H7N9)Aquatic birdsDomestic poultrySevere respiratory disease, limited human-to-human transmission
SARS-CoV-2Likely batsPossible intermediate hosts (e.g., pangolins, mink)Global pandemic with efficient human-to-human spread
Nipah virusFruit batsPigsEncephalitis and respiratory disease, occasional outbreaks with high mortality
Rabies virusWild carnivores, batsDomestic dogs (major amplifier)Fatal encephalitis if untreated
Table 4. Aspects of Host and Viral Interactions in Zoonotic Infections. A detailed review of the immunological barriers and escape mechanisms in viral zoonoses: host immune response, viral strategies to avoid immunity, genetic restrictions, vaccination studies, examples of specific viruses, and ethical issues.
Table 4. Aspects of Host and Viral Interactions in Zoonotic Infections. A detailed review of the immunological barriers and escape mechanisms in viral zoonoses: host immune response, viral strategies to avoid immunity, genetic restrictions, vaccination studies, examples of specific viruses, and ethical issues.
AspectExplanation
Host Immune Responses to Novel Viruses- The host’s innate and adaptive immune responses against novel zoonotic viruses.
- Antigen recognition of viral antigens, cytokine responses, and immune cell functions.
Viral Strategies to Evade Host Immune Defenses- Mechanisms of viruses to outwit host immune responses.
- Antigenic variation, immune mimicry, and inhibition of host immune effectors.
Impact of Host Immunogenetics- The host genetic factors underlying susceptibility and resistance to viruses of zoonotic origin.
- The genetic factors available in immune receptor diversity, HLA molecules, and immune pathway regulation.
Vaccination and Immunotherapy- Strategies of vaccine development against zoonotic viruses.
- Vaccine design. Challenges include antigen choice and adjuvants.
- The promise of monoclonal antibodies and antiviral immunotherapies.
Zoonotic Viruses with Unique Immune Responses- Examples of zoonotic viruses with unique immune-evasion strategies.
- Learnings from viruses such as HIV, influenza, and coronaviruses.
Cross-Species Immunity and Immune Memory- Cross-species immunity and immune memory in zoonotic infections.
- Implications for the emergence and outburst of zoonotic diseases.
Therapeutic Approaches and Challenges- Development of antiviral drugs and therapies for zoonotic infections.
- Resistance to drugs, treatment access issues, and side effects.
Ethical Considerations in Immunological Research- Ethical dilemmas that come with animal testing, vaccine trials, and human experimentation.
- Balancing the need for research with animal welfare and human rights.
Table 5. Applications of Ethical and Societal Considerations in Zoonotic Outbreaks. This table summarizes key real-world cases where ethical and societal dilemmas influenced zoonotic outbreak responses. Examples highlight the tension between immediate public health measures and long-term social or economic impacts, as well as the lessons learned for future policy and preparedness.
Table 5. Applications of Ethical and Societal Considerations in Zoonotic Outbreaks. This table summarizes key real-world cases where ethical and societal dilemmas influenced zoonotic outbreak responses. Examples highlight the tension between immediate public health measures and long-term social or economic impacts, as well as the lessons learned for future policy and preparedness.
CaseEthical/Societal DilemmaPublic Health/Policy ResponseLessons Learned
Ebola outbreak (2014–2016, West Africa)Bushmeat bans limited spillover but undermined food security and cultural practicesShort-term bans combined with awareness campaignsBalancing urgent interventions with long-term social needs is critical
H5N1 Avian Influenza (2003–present, Asia)Mass culling of poultry disrupted livelihoodsCompensation programs and trade restrictionsSupport for affected communities improves compliance with control measures
COVID-19 (2020–present, global)Vaccine distribution inequities between high- and low-income countriesCOVAX initiative and bilateral donationsGlobal health equity remains a central challenge
Table 6. This comprehensive table provides an overview of the emergence of SARS-CoV-2 and the global impact of COVID-19, covering topics from viral basics to ethical considerations and future preparedness.
Table 6. This comprehensive table provides an overview of the emergence of SARS-CoV-2 and the global impact of COVID-19, covering topics from viral basics to ethical considerations and future preparedness.
AspectExplanation
Global Spread and Pandemic Declaration- The rapid global transmission and the World Health Organization’s declaration of a pandemic.
- The impact on international travel, trade, and public health responses.
Epidemiological Characteristics- COVID-19 epidemiological patterns, including age and gender disparities.
- Understanding asymptomatic and presymptomatic transmission.
Public Health Measures and Interventions- Measures like social distancing, mask-wearing, and lockdowns to curb the spread.
- The development and deployment of diagnostic tests, treatments, and vaccines.
Economic and Societal Impact- The economic fallout, job losses, and disruptions to global supply chains.
- Mental health, social isolation, and disparities in access to healthcare.
Global Vaccine Distribution- The challenges of equitable vaccine distribution and vaccine diplomacy.
- The role of initiatives like COVAX in ensuring access to vaccines for all countries.
Variants of Concern- Emerging SARS-CoV-2 variants, their impact on transmission, severity, and vaccine effectiveness.
- Ongoing surveillance and adaptation of vaccines and treatments.
Ethical and Ethical Considerations- Ethical dilemmas related to vaccine allocation, vaccine passports, and individual liberties.
- The role of misinformation and vaccine hesitancy in the pandemic response.
Long-Term Consequences and Future Preparedness- Assessing the long-term health effects of COVID-19 (long COVID).
- Lessons learned for future pandemic preparedness, international cooperation, and research collaboration.
Table 7. Ethical dilemmas in zoonotic disease control.
Table 7. Ethical dilemmas in zoonotic disease control.
CaseInterventionBenefitEthical ConcernLessons Learned
Ebola (2014–2016)Bushmeat banReduced spillover riskThreatened food security, disrupted traditionsBalance urgent health needs with cultural and nutritional realities
COVID-19 (2020–2022)Global vaccine rolloutReduced global mortalityInequitable distribution between high- and low-income countriesBuild mechanisms for fair and timely access
Wildlife tradeMarket regulationReduced animal-to-human transmissionLivelihood loss for communitiesPair restrictions with alternative income strategies
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Aljabali, A.A.A.; Alqudah, A.; Bashatwah, R.M.; Alsharedeh, R.; Qnais, E.; Gammoh, O.; Mishra, V.; Mishra, Y.; El-Tanani, M.; Hatahet, T. Navigating Zoonotic Landscapes: From Genomic Insights to Ethical Frontiers. Zoonotic Dis. 2025, 5, 35. https://doi.org/10.3390/zoonoticdis5040035

AMA Style

Aljabali AAA, Alqudah A, Bashatwah RM, Alsharedeh R, Qnais E, Gammoh O, Mishra V, Mishra Y, El-Tanani M, Hatahet T. Navigating Zoonotic Landscapes: From Genomic Insights to Ethical Frontiers. Zoonotic Diseases. 2025; 5(4):35. https://doi.org/10.3390/zoonoticdis5040035

Chicago/Turabian Style

Aljabali, Alaa A. A., Abdelrahim Alqudah, Rasha M. Bashatwah, Rawan Alsharedeh, Esam Qnais, Omar Gammoh, Vijay Mishra, Yachana Mishra, Mohamed El-Tanani, and Taher Hatahet. 2025. "Navigating Zoonotic Landscapes: From Genomic Insights to Ethical Frontiers" Zoonotic Diseases 5, no. 4: 35. https://doi.org/10.3390/zoonoticdis5040035

APA Style

Aljabali, A. A. A., Alqudah, A., Bashatwah, R. M., Alsharedeh, R., Qnais, E., Gammoh, O., Mishra, V., Mishra, Y., El-Tanani, M., & Hatahet, T. (2025). Navigating Zoonotic Landscapes: From Genomic Insights to Ethical Frontiers. Zoonotic Diseases, 5(4), 35. https://doi.org/10.3390/zoonoticdis5040035

Article Metrics

Back to TopTop